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   i 
Abstract	  
 
Objective 
The objective of this study is to evaluate Present on Admission (POA) indicators as a 
new data source for which to model hospital readmissions.  POA indicators for have been 
in administrative claims data since 2008.  POA indicators’ primary purpose is to identify 
Hospital Acquired Conditions (HACs), which represent 0.14% of overall claims.  The 
remaining non-HAC POA data then falls into a category called “other.”   This study 
attempts to gage the secondary usefulness of POA indicators in aiding hospital 
readmission modeling. 
 
Methods 
This study used Medicare inpatient 5% Limited Data Sets (LDSs) for the years 2008 
through 2011.  Patient histories were assembled, index and readmission events were 
established, and datasets representing the primary diagnosis conditions of Acute 
Myocardial Infarction (AMI), Heart Failure (HF), and Pneumonia (PN) were extracted.  
CMS methodologies were followed consistent with the limitations of the source data.  A 
base logistic regression model was created to approximate the CMS hospital readmission 
models.  Three readmission periods were examined: 7 days, 15 days, and 30 days.  To 
this base, three POA variables were developed to address the following research 
questions: P1) Does the presence of any POA=no indicator (condition occurred after 
admission to hospital) found on an administrative claim correlate to readmission?  P2) 
Does the number of POA=no indicators found on administrative claim correlate to 
readmission?  P3) Does the hospital-specific POA usage rate per year across all available 
claims correlate to readmission?  These three POA variables were added to the three 
primary diagnosis datasets, and modeled across the three readmission periods, yielding a 
total of 27 individual statistical models.   
 
ii 
Results 
For variable P1, all three readmission periods for AMI were statistically significant at the 
95% confidence level indicating an increased likelihood of readmission with odds ratios 
for 7-day: 1.276 (1.051, 1.547); 15-day: 1.269 (1.076, 1.494); 30-day: 1.316 (1.139, 
1.520).  HF 15-day odds ratio just exceeded statistical significance at 1.061 (1.009, 
1.115).   For variable P2, results were at the cusp of statistical significance, but probably 
not clinical significance at all readmission periods.  For variable P3, HF and PN were 
significant, but showed a reduced likelihood of hospital readmission.  The data for 2008 
showed the widest errors, 2011 the narrowest, indicating an evolution toward more 
consistent POA use by providers.  The odds ratio for 2011 30-day readmission in the HF 
dataset returned 0.604 (0.476, 0.765), and PN returned 0.730 (0.539, 0.987). 
 
Conclusions 
POA indicators are not a homogeneous form of data.  POA indicators offer an added 
insight of patient complexity not previously available.  POA has personalities based on 
the primary diagnostic condition.  For AMI, there is a link between any POA=no 
condition during a patient stay and hospital readmission, but this is not true for HF nor 
PN.  When aggregating POA data at the hospital level, HF and PN show a reduced 
likelihood of hospital readmission, but this does not hold for AMI.  This effect could 
capture the provider’s documentation maturity, which is linked to better discharge 
practices, which in turn reduces readmission. 
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Executive	  Summary	  
Hospital readmission has gained national attention since the passage of the Patient 
Protection and Affordable Care Act, which authorized the Centers for Medicare and 
Medicaid Services (CMS) to identify primary diagnostic conditions having high 
readmission rates.  Under the law, CMS has statutory authority to reduce reimbursements 
to hospitals with greater than expected readmissions.  Penalties are expected to start at 
~$280M the first year and climb over the next two, with some estimates predicting them 
to level off around $750M annually.  CMS now has a stick to wield against hospitals as a 
means of changing their behavior.  Individual hospitals and provider networks need to 
become aware of patient readmission to avoid exceeding annual penalty thresholds.  
Policy and research agencies such Agency for Healthcare Research and Quality (AHRQ) 
and the National Quality Forum (NQF) also monitor readmissions.  And CMS itself 
levies the penalty based on calculated expected rates versus actual rates.   
Most hospital readmission models at the national level use administrative claims data 
as their base, not clinical data, resulting in weaker data and more assumptions.  At first 
glance, additional patient data would be valuable to those modeling readmission because 
it originates directly from the inpatient stay.  Hospital Acquired Conditions (HACs) are a 
subset of International Classification of Disease, 9th Revision, with Clinical Modification 
(ICD-9-CM) codes which contain the following categories: object left in after surgery, air 
embolisms, blood incompatibility, catheter-associated urinary tract infection, pressure 
ulcers, vascular catheter-associated infection, surgical site infections, falls, poor glycemic 
control, deep vein thrombosis or pulmonary embolism.  Present-on-Admission (POA) 
data is data collected during the patient’s hospital stay and added to the administrative 
claim.  A HAC condition that is not POA can be termed a HAC event and will not be 
reimbursed by CMS.  POA data describes the state of secondary diagnosis codes as 
occurring prior to admission or being acquired at the hospital after admission.  The 
distinction is subtle but offers a glimpse into the patient’s stay.  POA data is intended for 
the HAC program in order to identify which claims have conditions which could only be 
caused by bad care.  POA are on all secondary conditions for the majority of Medicare 
iv 
claims.  POA is the means to identifying when a HAC has occurred.  It is this “hospital-
acquired” aspect which could be valuable to understanding readmission.  Think of it as a 
loose proxy for patient complications during stay. 
This thesis attempts to create a base hospital readmission model across 4 years of 
Medicare, 5% Limited Data Set (LDS) administrative claims data.  The intent of the base 
model is to approximate the model used by CMS given the data limitations.  Into this 
base model, new variables were introduced representing three different views of POA 
data: two at the individual claims level and one aggregated at the provider level.  Three 
individual datasets were extracted, one for each primary diagnosis condition of interest: 
Acute Myocardial Infarction (AMI), Heart Failure (HF), and Pneumonia (PN).  Three 
readmission periods were also selected for modeling based on results from the literature 
search: 7 days, 15 days, and 30 days from index claim.  Readmission was considered for 
all-cause only.  Logistic regression captured baseline estimates to which POA variables 
were then added.  A total of 27 models were constructed. 
Results indicate that the presence of at least one POA=no indicator on an 
administrative claim was statistically significant for AMI across all time periods showing 
an increased likelihood of readmission, when controlling for all other variables.  The 
effect was larger than gender and as large as beneficiary age >= 80 years.  This variable 
was not statistically significant for HF nor PN.  The second POA variable approached or 
just exceeded statistical significant for all conditions and readmission time periods and 
had small odds ratios producing a small effect.  The final variable was not significant for 
AMI at any time period nor any readmission period, but was statistically significant for 
HF and PN.  The effect was negative, indicating a reduction in readmission odds.  
It is curious that claim-based POA variables indicate increased odds for AMI but not 
HF nor PN.  This could be due to AMI being more surgical in treatment compared to HF 
and PN, which tend toward treatment of chronic or exacerbating conditions.  HF and PN 
may also be associated with other comorbidities requiring greater treatment in general.  It 
could also be that hospital-based POA variables tend to capture hospital documentation 
practices including discharge-planning, which is associated with reducing hospital 
v 
readmission.  The effect speaks to the idea that POA data is not homogeneous.  POA data 
has different characteristics depending on primary diagnosis code. 
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   1 
1 Research	  Problem	  
1.1 Introduction	  
“Readmission” refers to a patient’s being admitted to a hospital within a certain time 
period from an initial hospital visit’s discharge.[1]  Hospital readmission rate for 
Medicare patients can range as high as 20% of patients per year and cost upwards of 
$17.4 billion annually[2].  Readmission time period varies from 7, 15, 30, 60, 90 days or 
more, but the most commonly used definition refers to a 30-day period.  Hospital 
readmissions are a function of the patient’s disease state, comorbidities, and 
demographics, but are also a function of hospital care, principal diagnosis, procedure 
timeliness and execution.  Further still, readmission can be influenced by the community: 
the type of post-acute care available and general community mores toward health care in 
general.  Many of these factors are not in the hospital’s control.  Centers for Medicare 
and Medicaid Services (CMS) is now evaluating hospitals and assessing a penalty for 
excessive readmissions, which in 2013 amounted to $280M.  
Hospital Acquired Conditions (HACs) are situations arising from substandard 
hospital care resulting in patient harm.  As of 2008, CMS is no longer reimbursing 
providers for HAC conditions.  (Note: “provider” throughout this document refers to the 
institution certified by Medicare to supply services to its beneficiaries.  It does not refer 
to a single physician.)  Implementing the HAC program required altering administrative 
claim forms to include a means of identifying whether or not the patient’s secondary 
diagnosis conditions were Present-on-Admission (POA) or the condition was acquired 
after the patient was admitted to the hospital.   
Is there a relationship between POA indicators and hospital readmission?  As a 
readmission explanatory variable, POA data is interesting because it could increase data 
richness specific to the patient’s stay.  This is in contrast to incorporating external data, 
such as municipal demographics, hospital case mix, economic considerations, or even 
community views of health care.  To date, HAC/POA data has not been incorporated into 
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many statistical models.  The purpose of this study is to understand and assess the 
usefulness of POA indicators as a potential hospital readmissions predictor.   
Understanding this study requires understanding a reasonable background of both 30-
day hospital readmission and HAC data.  Section 1.2 investigates readmission from the 
vantage point of national reporting as opposed to state-level or hospital-specific 
reporting.  It takes into account some disease specifics as well as disease progression as a 
readmission factor.  Section 1.3 describes the background of HACs.  Of interest here is 
not so much the conditions themselves, but understanding the administrative claims 
changes needed to implement HAC reporting via POA indicators.  
1.2 30-­‐Day	  Hospital	  Readmission	  Background	  
1.2.1 Origins	  of	  Readmission	  
Hospital readmission has been the subject of investigation for years.  A reasonable 
point from which to consider contemporary studies is a literature review conducted by 
Benbassat and Taragin, 2000, titled “Hospital Readmission as a Measure of Quality of 
Care – Advantages and Limitations.”[3] They make the observation that most studies 
investigated had concluded readmissions were “caused by patient frailty and chronic 
disease progression.”  They also identify a wide range of between “9% and 48% of 
readmissions have been judged to be preventable … and were associated with 
substandard care.”  Benbassat and Taragin reviewed articles and books published over 
the previous 10 years.  At that time of publication, no national system for tracking 
readmission existed.  Results were limited to clinical records collected from small 
documentation reviews and extrapolated upward per condition or per hospital per state.   
The Hospital Inpatient Quality Reporting (IQR) program was mandated by Section 
501(b) of the “Medicare Prescription Drug, Improvement and Modernization Act (MMA) 
of 2003”[4], directing hospitals participating in the Inpatient Prospective Payment 
System (IPPS) to start reporting quality information on core measures.  After collection, 
this data was made available to consumers via CMS’s HospitalCompare website, 
http://www.medicare.gov/hospitalcompare, with the ultimate hope of increasing patient 
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care by adherence to these basic quality measures.  MMA also authorized CMS to reduce 
reimbursements to hospitals not successfully meeting the quality guidelines.  CMS also 
uses the data to calculate payment rates under the Hospital Value-Based Purchasing 
(VBP) program.[5]  The IQR program was extended to collect additional data via the 
Section 5001(a) of Pub. 109-171 of the Deficit Reduction Act (DRA) of 2005[6].   
Circa mid-2000s, Jencks, Williams, and Coleman cite an overall readmission rate of 
20%, meaning 1 in 5 hospitalizations had a readmission within 30 days of a hospital 
discharge.[7]  Hospitals with rates below the baseline readmission rate were praised, 
while those hospitals with rates above the baseline were shamed.  But other than the 
praise and shame there was no compelling reason for providers to alter behavior. 
Medicare Payment Advisory Commission (MedPAC), Congress’s Medicare advisory 
agency, issued “Payment policy for inpatient readmissions” in June 2007, finding 
Medicare spending on 30-day readmission amounted to $15 billion resulting from an 
estimated 17.6% all-cause annual readmission rate.[8]  Within this report, readmission 
periods were considered for 7-day, 15-day, and 30-days from the index (initial) 
discharge.  The report also urged readmission definition away from hospital-specific rates 
and towards specific medical conditions citing “hospitals that concentrate on joint 
replacements are likely to have lower readmission rates than hospitals that concentrate on 
cardiac care” when comparing hospital-rate only. 
It wasn’t until the “Patient Protection and Affordable Care Act of 2010” (ACA) that 
CMS had the authority under Section 3025 to form the “Hospital Readmission Reduction 
Program” in order to collect hospital readmission data and withhold reimbursement to 
hospitals exceeding an expected annual threshold.[9]  From a list of top ten readmission 
conditions, CMS selected three for the first implementation phase: Acute Myocardial 
Infarction (AMI), Heart Failure (HF), and Pneumonia (PN).  These were selected because 
they are costly, frequent, and were determined to have the highest readmission rates for 
“preventable” conditions.  Data collection started immediately, and reimbursement 
payments would take effect 2013Q4.  Reductions are calculated as shown in Figure 
1.[10] 
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Figure 1.  CMS readmission adjustment calculation. 
 
Providers now had a reason to monitor patients for readmission.  Using data collected 
via the IQR, CMS started to publish 30-day hospital readmission rates calculated for each 
provider using the administrative claims data, all of which was posted on the 
HospitalCompare website.  These rates let consumers know about a hospital’s implied 
quality via the readmission metric.   
Between the passage of the ACA and June 2011, CMS had completed the following 
with respect to the readmission program: 
• Defined 30 days as the readmission time period for all-cause readmission  
• Limited reimbursement of readmission conditions to AMI, HF and PN 
• Established policy consistent with the National Quality Forum (NQF) 
methodology for calculating excess hospital readmissions for the selected 
conditions 
• Defined readmission methodology consistent with NQF and MedPAC 
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1.2.2 Determining	  Which	  Claims	  Are	  Readmissions	  
Understanding readmissions is a tricky business.  Early attempts to calculate 
readmission used all available claims to generate an “overall rate” hospital rate: any 
patient, any condition, any time.  This approach is problematic for a number of reasons.  
Patients with a progressing disease state return more often and appear to have higher 
readmission “caused by substandard care.”  Comorbidities confound readmissions such 
as kidney problems and heart problems, and meeting different staff within a hospital 
setting, resulting in treatment for one conditions appears as a readmission for the other.  
Linking unrelated conditions via readmission inflates readmission rates.  A better 
alternative supported by NQF is to separate claims based upon health condition using sets 
of ICD-9 diagnostic codes found in the principal diagnosis fields – looking across all 
patients with AMI, for example.  These types of claims have a common set of criteria: 
patients have similar conditions, the administrative data has similar Diagnostic-Related 
Groups (DRGs), similar length of stay, similar costs, etc.   
Before proceeding too far, it will be necessary to understand the following terms used 
within this study:   
Administrative claim:  Any claim for service provided by an inpatient service 
provider containing a summary of services rendered for a patient at a hospital 
meeting requirements set forth by CMS 
Potential index claim:  Any administrative claim meeting eligibility requirements 
for readmission study (ex: claim must be from U.S. state or D.C., patient must be 
discharged alive, etc.) 
Index claim:  A status given to potential index claims that have an associated 
readmission claim  
Readmission claim:  A status given to potential index claims that have an 
associated index claim 
The following diagrams illustrate CMS’s adopted readmission definitions.  Suppose 
Patient A goes into the hospital for a condition leading to (fill in the blank).  Patient A 
has an operation, then gets moved into another room on a different floor of the hospital.  
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Several days later, the patient is sent across the street for rehabilitation services to get the 
patient up on their feet and able to partake of the activities of daily living.  Patients stay 
in the rehab unit for many more days until discharged and sent home.  For the average 
researcher with access to no clinical data but lots of administrative data, this patient’s 
visit to a single provider can instead appear as several events (Figure 2).  Providers divide 
resources for the purposes of billing and reimbursement, making a single visit to the 
hospital into a chain of disconnected administrative claim records. 
 
Figure 2.  Administrative claim history for a single episode of care. 
 
One cannot look at a single administrative claim and determine if it is a readmission.  
There has to be a context from which to judge.  Building the context requires aligning 
claim records by patient and within patient claims by date.  Knowing which claims are 
upstream events and which are downstream events is still not enough to determine 
readmission status.  CMS’s hospital readmission reduction program focuses on short-
term acute care hospitals and their care plans for the patient post-discharge.  
Rehabilitation, psychiatric, long term care, and outpatient facilities are not part of the 
hospital readmission reduction program.  Consequently, these claims are ineligible for 
this study and must be removed from further consideration.  Each claim is subject to 
screening, the purpose of which is identifying “potential index” claims as the source from 
which to judge downstream claims as readmissions.  The goal is to find the last link in the 
claims chain responsible for the post-discharge planning (Figure 3). 
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Figure 3.  Identifying "potential index" claims. 
 
Figure 3 contrasts the cases of Patient A and Patient B.  In the case of Patient B, there 
is a case of escalation from one short-term hospital to another.  The administrative claims 
look similar to that of Patient A except for the point at which the 30-day window starts. 
Because C1 transferred the patient to a different hospital, the readmission clock starts 
with the following C2 claim.  Again, the purpose of identifying “potential index” claims 
is to link any readmission with the appropriate hospital, in this case the last hospital in the 
chain and one responsible for patient discharge planning.   
CMS uses a combination of MedPAC- and NQF-derived criteria to determine which 
administrative claims are eligible and which are not.  Some of the exclusion criteria are: 
• Claim not from a short-term acute care hospital 
• Claim not from a U.S. or D.C. hospital 
• Zero-day claims (having a utilization day count of ‘0’, patient didn’t spend the 
night in the facility)  
• Transfer claims (claims where the delta between through data and admission 
date is ‘0’) 
• Rehabilitation or psychiatric hospital claims 
• Patient <65 years old at time of hospitalization 
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• In-hospital death claims 
• Cancer hospital claims (disease progression in combination with cancer 
treatment and its side effects confound readmission modeling) 
• Patients who leave against medical advice 
Claims meeting these conditions would be removed from the patient’s claim history.  
After removing all ineligible claims, actual “index” and “readmission” claims are 
identified using the earliest through dates from each patient’s claims records.  There are 
three considerations illustrated in Figure 4 below.   
 
Figure 4.  Identifying single readmission event. 
 
For Patient C, the distance between the claims exceeds the readmission window and 
does not count as a readmission event.  Patient D, however, has a claim falling within the 
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readmission window of another claim.  This is the normal case, and these two claims 
become a readmission event.  An additional complication arises when patients are 
diagnosed with a condition on one claim, but are discharged pending scheduled surgery.  
In the case of Patient E, the second hospitalization appears as a readmission event from 
the first visit, but it isn’t.  The question of planned versus unplanned is a function of 
disease state, urgency, hospital or doctor availability, patient’s ability to endure a surgical 
event, etc.  These planned events present an inflated hospital readmission ratio by 
increasing the numerator counts.  These situations can be common at larger institutions 
negatively affecting the provider.  CMS methodology filters out planned events from 
readmission calculations.  Patients with AMI may have staged or planned readmissions, 
but HF and PN do not. 
In addition to determining individual claim eligibility based upon data within a given 
claim record, some models also add conditions constraining eligibility based upon 
upstream claims by requiring a 30+ day buffer between “index” claims.  The motivation 
behind this logic addresses the condition when a bad health situation turns worse 
requiring more hospital visits to stabilize a patient.  Under this condition, the claim 
history gets confused, and filtering out the additional claims produces a better 
readmission signal.  This is true from a provider prospective, but patient advocates point 
to repeated trips to the hospital as a sign of poor quality.  CMS has adopted the second 
approach as its methodology. 
Patients near end-of-life or with chronic disease progression are more likely to need 
additional care.  These patients have many “potential index” claims in their 
administrative histories and most of these claims have deltas smaller than the 30-days.  
Figure 5 illustrates the situation for Patient F involving multiple readmission events in 
close proximity to one another.   
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Figure 5.  Identifying multiple readmission events for a single patient.   
 
When considering the question, “how many readmission events are there?” most 
methodologies fall into one of three cases.  Option 1 adopts the view that a claim can be 
either an index or a readmission, but cannot be both.  This is another method to remove 
muddled claim histories from the readmission assessment process.  Option 2, from the 
provider perspective, it is plausible to see claim C3 as still somehow involved as 
correcting the C1 and C2 event chain.  From the patient perspective, another trip to the 
hospital could be seen as substandard care leading to Option 2, where all claims could be 
either an index or a readmission.  In “Working Paper: Simple Methods of Measuring 
Hospital Readmission Rates” [11], the authors cited another approach of counting any 
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claim falling within the readmission period of a “potential index” claim as a readmission.  
This is Option 3, and it is included to give perspective on what approaches are under 
consideration when defining readmissions.  Option 3 has a peculiar effect of producing a 
readmission ration greater than 1.0 caused by an artificially large numerator.  It is this 
reason the America’s Health Insurance Plans, Center for Policy and Research list this as a 
non-preferred method.  CMS uses Option 2 in its readmission calculation methodology. 
1.2.3 Determining	  Readmission	  Rates	  
Given that a repeatable, reliable method for determining readmission events has been 
defined, the problem now turns toward aggregating results and determining readmission 
rates.  Readmission work of the 1990s attempted to use the individual patients as a point 
of reference: how many readmissions does a patient and peer group experience?  The 
trouble here is identifying peer groups.  At the hospital level?  Individual providers don’t 
have access to their peer’s data resulting in peer group rates equaling hospital rates.  
Patients are also problematic as they can travel from one hospital in their region to 
another for care, thus breaking the chain of events.  This method produced wildly varying 
results and was consequently dropped.   
Another approach concentrated on the disease instead of the patient.  Hospitals 
treating AMI or PN should be comparable.  This method uses the principal diagnostic 
code of the index and of the potential-readmission claims to determine if an actual 
readmission event should be counted.  If a patient treated for PN had to go back to the 
hospital to be treated for PN again, that would count as a readmission.  However, this 
method under counts readmissions and allows for gaming.  The provider has access to the 
clinical data while CMS does not.  The temptation to alter a second PN into something 
that does not count as readmission is too great particularly when peer providers are 
gaming the system.  This approach is further complicated by confounding because the 
disease condition under investigation would be represented in a statistical model as both 
an input variable and an output variable: an AMI claim used to predict an AMI 
readmission.  Another set of readmission studies form the 1990s attempted to limit 
readmissions to those claims relating to the principal diagnosis of the index claim.  As a 
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concept, this approach was abandoned for two reasons.  First, every hospital is 
responsible for treating the whole patient, not just a specific disease, procedure, etc.  
Second, readmissions occurring at the same hospital are then open for potential gaming; 
hospitals fudging numbers to appear better than they really are. 
Aggregating only at the hospital level also proved unsatisfactory.  In this method, all 
readmissions are counted and divided by the number of claims.  MedPAC [7] describes 
the primary limitation this way, “hospitals that concentrate on joint replacements are 
likely to have lower readmission rates than hospitals that concentrate on cardiac care.”  
Case mix can allow a statistical model to control for the types and numbers of patients a 
hospital serves.  Service mix can allow a statistical model to control for the types of 
offerings in which a hospital specializes.  Combining both should allow hospital-level 
comparisons for readmissions.  But the results are still unsatisfactory as the hospital is not 
the correct unit for investigation.   
The final recommended solution by MedPAC and NQF came in the mid-2000s with 
readmission aggregation at the hospital level via specific diagnostic conditions.  This 
method identifies all indexes and readmissions using all administrative claims for each 
patient.  It then identifies index events by principal diagnostic condition (find all AMI-
only events, for example).  From this pool, all-cause readmission (any reason the patient 
returns is suspicious) rates are calculated.  This method is the current best-practice 
method for comparing how each hospital handles each condition.  Different diagnostic 
conditions have different readmission characteristics and can mask one another if 
combined, so removing the confounding aspect of multiple medical conditions creates a 
better statistical model.  CMS uses this approach as the basis for its readmission 
adjustment factor calculation. 
As part of the hospital quality program, CMS monitors risk-standardized readmission 
rates for three most common or most expensive conditions: AMI, HF, and PN.  It 
publishes those statistics on its HospitalCompare website.  CMS created a model using 
the previous three years’ worth of data collected for each hospital to calculate an 
expected readmission rate.  Those hospitals with actual readmission rates exceeding the 
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expected rates are penalized a proportion of the annual reimbursement for those 
monitored conditions.  The ACA 2010 specifies a maximum penalty of 1% for the first 
year, 2% for the second, and maxing out at 3% thereafter.  Penalties commence with 
2013.  The first year’s assessed penalties for 2013 amount to $280M.  Total estimated 
readmissions are expected to run into the billions of dollars annually.  The penalties may 
seem small in comparison to total reimbursement expenditures, but the purpose of the 
penalty is to change hospital behavior by redirecting hospital’s attention to outcomes and 
readmission.  The purpose is not to recoup all losses and shut facilities down. 
1.3 HACs/POA	  Background	  
1.3.1 Sentinel	  Events	  
A reasonable place as any to understand the importance and advent of HACs is with 
the 1999 Institute of Medicine book, To Err is Human: Building a Safer Health 
System.[12]  The authors revealed the lives lost or harmed and lost opportunity cost 
wasted because of medical errors in the American health care system.  There was a 
certain shock value to the report: “at least 44,000 people, and perhaps as many as 98,000 
people, die in hospitals each year as a result of medical errors.” How could the U.S. 
health care system be in this shape?  The report’s impact raised awareness at an 
institutional level, a state level, and national level regarding the magnitude of bad 
medical practice. 
As of the late 1990s, quality efforts were ad hoc, provider-based or department-based 
within a provider.  No larger plan existed to identify, track, and report on errors made in 
the health care system, and few states mandated quality initiatives.  Indeed, there existed 
a culture intolerant of errors and mistakes, preventing the acknowledgement that these 
types of things might happen in the first place.  The authors recommended many things, 
and among them two stand out: First, standardize medical error reporting mechanisms via 
the formation of an agency to pursue patient safety and reporting.  To accomplish this, 
the authors recommended secondly to target a limited number of hazardous event types 
and to concentrate action to reduce or eliminate them.  The first would ensure congruent 
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and consistent reporting across states, and the second would aim for a higher probability 
of success because the goals would be smaller and more well-defined. 
To Err also included a summary of state-based adverse event reporting as its 
Appendix D.  It demonstrated how much variability existed within the reporting systems 
at that time.  These 13 states, CA, CO, CT, FL, KS, MA, MS, NJ, NY, OH, PA, RI, and 
SD, representing approximately 42% of the US, had their own quality reporting systems 
in place, but those systems varied by what health conditions were tracked, the terms used, 
consequences if any for not following the standard, and visibility of final reports.  Would 
results be made public or would they be private?  The remaining states had no reporting 
or little state-level reporting.  Collecting the data was one issue.  Disseminating the 
results of collection and analysis was another as hospitals were not interested in having 
any “dirty laundry” aired in public.   
A third recommendation from To Err was to establishment of  what became known as 
sentinel events – things that were so bad, so egregious, no one could call these legitimate 
conditions or side-effects of reasonable care.  These were the fore-runners of what would 
become known as HACs. 
1.3.2 Serious	  Reportable	  Events	  /	  Never-­‐Events	  
Despite the reference to To Err in nearly all papers defining health care quality, there 
are other contemporary sources who had arrived at the same conclusion.  In 1998 just 
prior to To Err publication, the Quality Interagency Coordination Committee (QuIC) was 
formed by Presidential directive, 13-Mar-1998 [13].  It was charged “to ensure that all 
Federal agencies involved in purchasing, providing, studying, or regulating health care 
services are working in a coordinated way toward the common goal of improving quality 
of care.”[14]  The Committee chair is the Secretary of Health and Human Services (HHS) 
with day-to-day operations directed by another chair, the Director of the Agency for 
Healthcare Research and Quality (AHRQ).  The QuIC Committee quickly recognized the 
importance and significance of To Err’s findings as being in alignment with the 
viewpoint of driving national health care toward consistent delivery, higher quality and 
responsibility.  The Committee’s structure provided backing to the Health Care Finance 
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Administration, as CMS was called in 2000, to address patient safety concerns brought 
up by the To Err report.   
Another organization, the NQF, was created in 1999 at the time of To Err’s 
publication by a coalition of public and private partners under a different but related 
directive, “to promote and ensure patient protections and health care quality through 
measurement and public reporting.”[15]  CMS, at the direction of QuIC, directed NQF to 
“identify a set of patient safety measurements that should be a basic component of any 
medical errors reporting system.”[16]  The logic and virtue in NQF’s recommendation is 
that any health care quality reporting system containing adverse events (however defined) 
would contain a set of similar conditions because these conditions are so basic that every 
provider should already be tracking them.  NQF would then standardize the definitions 
and reporting framework. 
NQF presented this early framework in 2002.  It included events that were “shocking” 
-- medical errors that appeared to happen regularly and were indicative of such poor 
health care that those events should just never occur.  These became known as “never-
events.”  NQF identified three criteria all potential never-events conditions must meet:   
a) The condition is clearly identifiable as an error.   
b) The condition is serious in nature, resulting in death or serious injury.   
c) The condition is preventable if standard care guidelines are followed.   
NQF proposed 28 conditions meeting these criteria, and divided them into 6 
categories as seen in below in Table 1. 
Table 1.  NQF’s 2002 definitions of serious reportable events, aka never-events. 
Category Never-events 
Surgical Events 
 
1.1. Surgery performed on the wrong body part 
1.2. Surgery performed on the wrong patient 
1.3. Wrong surgical procedure performed on a patient 
1.4. Unintended retention of a foreign object in a patient after surgery or other procedure 
1.5. Intraoperative or immediately postoperative death in an ASA Class I patient 
Product or Device Events 
 
2.1. Patient death or serious disability associated with the use of contaminated drugs, 
devices, or biologics provided by the health care facility 
2.2. Patient death or serious disability associated with the use or function of a device in 
patient care in which the device is used or functions other than as intended 
2.3. Patient death or serious disability associated with intravascular air embolism that 
occurs while being cared for in a health care facility 
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Category Never-events 
Patient Protection Events 
 
3.1. Infant discharged to the wrong person 
3.2. Patient death or serious disability associated with patient elopement (disappearance) 
3.3. Patient suicide, or attempted suicide resulting in serious disability, while being cared 
for in a health care facility 
Care Management Events 
 
4.1. Patient death or serious disability associated with a medication error (e.g., errors 
involving the wrong drug, wrong dose, wrong patient, wrong time, wrong rate, 
wrong preparation, or wrong route of administration) 
4.2. Patient death or serious disability associated with a hemolytic reaction due to the 
administration of incompatible blood or blood products 
4.3. Maternal death or serious disability associated with labor or delivery in a low-risk 
pregnancy while being cared for in a health care facility 
4.4. Patient death or serious disability associated with hypoglycemia, the onset of which 
occurs while the patient is being cared for in a health care facility 
4.5. Death or serious disability (kernicterus) associated with failure to identify and treat 
hyperbilirubinemia in neonates 
4.6. Stage 3 or 4 pressure ulcers acquired after admission to a health care facility 
4.7. Patient death or serious disability due to spinal manipulative therapy 
Environmental Events 
 
5.1. Patient death or serious disability associated with an electric shock while being 
cared for in a health care facility 
5.2. Any incident in which a line designated for oxygen or other gas to be delivered to a 
patient contains the wrong gas or is contaminated by toxic substances 
5.3. Patient death or serious disability associated with a burn incurred from any source 
while being cared for in a health care facility 
5.4. Patient death or serious disability associated with a fall while being cared for in a 
health care facility 
5.5. Patient death or serious disability associated with the use of restraints or bedrails 
while being cared for in a health care facility 
Criminal Events 6.1. Any instance of care ordered by or provided by someone impersonating a physician, 
nurse, pharmacist, or other licensed health care provider 
6.2. Abduction of a patient of any age 
6.3. Sexual assault on a patient within or on the grounds of a health care facility 
6.4. Death or significant injury of a patient or staff member resulting from a physical 
assault (i.e., battery) that occurs within or on the grounds of a health care facility 
 
Because these unambiguous events can be distinguished from other conditions, they 
can be measured and therefore reported.  Two recommendation goals stand out: 
increasing patient safety by reducing medical errors, but also public accountability of 
clinicians and institutions who have committed these errors.  Both are accomplished via 
public event reporting.  These are sound, logical arguments toward the goal of increasing 
hospital quality.  However, as of the mid-2000s, there were no reporting agencies at the 
federal level collecting this type of data.  Nor were there any agencies able to mandate it.   
Things were different at the state level.  By 2007, a report on state-level patient 
safety[17], identified 10 states, CA, CT, IL, IN, MN, NJ, OR, VT, WA, and WY, that had 
voluntarily adopted some or all of the NQF never event guidelines into their own 
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departments of health.  Minnesota is one example that led the way by legislated reporting 
starting in 2003[18], resulting in its first patient safety report dated Jan-2005. 
1.3.3 HACs	  
With the passage of the DRA of 2005 Section 5001(c)[19], Congress directed CMS to 
alter DRG payments in order to limit inpatient hospital reimbursements for certain 
conditions that could have reasonably been prevented had the hospital followed standard-
of-care guidelines.  The “Quality Adjustment in DRG Payments for Certain Hospital 
Acquired Infections” section of the DRA Section 5001(c) gave CMS direction to identify 
conditions meeting these three criteria:  
• Condition has high cost or high volume, or both. 
• Condition results in higher DRG payment when present as secondary diagnosis. 
• Condition could reasonably have been prevented, as determined by application 
of evidence-based guidelines. 
Prior to the DRA Section 5001(c), Medicare would reimburse a hospital more for 
treating a patient whose inpatient stay cost more as a result of the hospital’s own faulty 
actions or inactions.  A New York Times article “Not Paying for Medical Errors”, 
explains that a patient getting an infection after being admitted to a facility: “even if the 
infection is caused by sloppy sanitary practices in the hospital itself … [results in] 
rewarding incompetence rather than penalizing it.”[20]  Wald and Kramer[21] add to the 
sentiment by focusing on one condition, Catheter-Associated Urinary Tract Infections 
(CAUTIs), showing $400M annually spent treating infections, most of which, in their 
opinions, could have been prevented.  They also note providers may be reimbursed 60% 
more for the same underlying conditions because of complications caused by the 
infection the provider failed to prevent.  By way of example, they cite a Colorado 
hospital’s costs to treat a patient with AMI (Table 2).  
They further estimate an annual expenditure of $400M for just to treat complications 
for this one condition.  With the DRA Section 5001(c), CMS gained the ability to restrict 
reimbursement to those patient-centric conditions and not to those that are hospital 
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related.  In the previous example, the hospital would have to absorb the $3,468 difference 
from the standard of care compared to the cost to treat the original condition. In addition, 
the law prevents hospitals from billing the patient for the difference.  These legal actions 
attempt to focus hospitals on the quality of care they provide by removing a financial 
incentive to tolerate poor quality. 
Table 2.  Additional reimbursement for CO hospitals cited by Wald and Kramer. 
AMI Patient Hospital Costs 
Patient with no complications $5437 using current standard-of-care 
Patient with a UTI complications $6721, ~23% more than standard 
Patient with major UTI complications $8905, ~63% more than standard 
 
 
To implement a program limiting reimbursement, CMS would need to do three 
things. 
1. Publish a HAC list consisting of International Classification of Disease, 9th 
Revision, with Clinical Modification (ICD-9-CM) codes so providers could 
establish programs targeting these codes. [22] 
2. Alter existing DRG payments and codes to segregate conditions by their 
severity:  a) condition is baseline normal case, b) condition has Complications 
or Comorbidities (CC), or c) condition has Major CC (MCC).  This is called 
the Medicare Severity-DRG (MS-DRG) and offers additional reimbursement 
for additional care when conditions are warranted. 
3. Define a POA indicator as “yes” or “no” for each secondary diagnosis code 
submitted on each claim containing a HAC condition to enable CMS to detect 
HAC/POA conditions. 
Payments would be held to the base MS-DRG severity rates if a HAC condition exists 
on the administrative claim, and that HAC happened to the patient after admission to the 
hospital.  HAC data was phased in starting as a voluntary system in 2007Q4, becoming 
mandatory in 2008Q4.  
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1.3.3.1 Publish	  a	  HACs	  List	  
Word spread through the health care community in the early 2000s to the public about 
U.S. hospitals and never-events, raising the outrage surrounding Medicare paying for bad 
care under the fee-for-service agreements.  Awareness eventually moved to Congress.  
With the passage of the DRA of 2005, signed into law in 2006, Congress granted 
authority to CMS to define conditions such as never-events and to create a reporting 
structure capable of processing claims limiting reimbursement in cases of bad health 
care-caused conditions.  It was from NQF guidelines which CMS adopted its first list of 
HACs.  The two lists are not congruent because they target different populations.  The 
audience for Serious Reportable Errors from NQF are U.S health care patients whose age 
could be anywhere from infant to elder.  CMS conversely needed conditions targeting 
patients whose ages are 65+ years old.  Per the DRA section 5001(c), CMS was called to 
identify at least two conditions meeting the criteria, and to publish those no later than 
2007Q3 such that providers could start to report on them.  CMS chose eight conditions 
for their initial implementation, and expanded the list to ten conditions effective 
2009Q4.[23]  (See Table 3.) 
Table 3.  CMS’s definition of HAC categories. 
Hospital Acquired Conditions ICD-9-CM Diagnosis Code 
Object left in surgery 998.4, 998.7 
Air embolism 999.1 
Blood incompatibility 999.60, 999.61, 999.62, 999.63,  999.69 
Catheter-associated urinary tract infection 996.64  
Pressure ulcers 707.23, 707.24 
Vascular catheter-associated infection 999.31-999.33 (new 2007) 
Surgical site infection (mediastinitis) 519.2 plus 36.10-36.19 procedure code 
Falls  800-839, 850-854, 925-929, 940-949, 991-994 
Manifestations of poor glycemic control 250.10–250.13, 250.20–250.23, 251.0, 249.10–
249.11, 249.20–249.21 
Deep vein thrombosis or pulmonary embolism 
following certain orthopedic procedures 
415.11, 415.19, 453.40–453.42  
plus one of the following procedure codes:  
00.85–00.87, 81.51–81.52, or 81.54 
1.3.3.2 Alter	  Existing	  DRG	  Payments	  
The DRA Section 5001(c) gave CMS the ability to modify the DRG payment 
definitions and the administrative claims data upon which the DRG is based.  DRGs were 
first proposed in 1980 to address the rising cost of Medicare spending by proposing a 
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reimbursement system for providers to control their own costs through common payment 
for a given medical condition.  The idea behind DRGs is to gather clinically cohesive 
groups of medical treatments together and provide one base reimbursement amount.  For 
example, under a simple fee-for-service model, all treatments, drugs, equipment, therapy, 
etc., for a Coronary Arterial Bypass Graft (CABG) procedure would be billed separately.  
All hospitals would be reimbursed for what they billed.  Under the DRG system, an 
average cost for the CABG and associated costs is reimbursed.  The resulting 
intermediate reimbursement amount is then altered based on hospital status, teaching 
institution status, patient outlier conditions, etc.  The base amount varies based on the age 
of beneficiary, gender, etc.  The provider has a financial incentive to treat the patient 
more efficiently, a cost below the reimbursed amount, resulting in a financial saving or 
income to the hospital.  Providers exceeding the reimbursement cost would then realize a 
financial loss to the institution for that claim.  Hospitals contracting with CMS to provide 
Medicare service for seniors agree to reimbursement under the IPPS utilizing DRGs. 
CMS replaced the existing DRG (Version 25) definition with an extended DRG 
definition (Version 26) which incorporated a relative complexity or severity measure.  
CMS called it the MS-DRGs.  Prior to Version 26, conditions which complicate 
treatment were not represented well.  Hospitals serving more complicated patients were 
not reimbursed more for the additional services needed for the complication.   
Starting with version 26, the Grouper application, could select between multiple MS-
DRG codes for the same base condition which are differentiated only by the severity of 
the patient’s overall conditions: base condition equals base reimbursement.  Grouper 
would select the code ‘CC’ to designate patients with “complications or comorbidities,” 
(also confusingly defined as “complicating conditions” depending upon the source), 
reflecting the providers efforts to treat patients above the normal case because the patient 
required a longer hospital stay, additional drugs and monitoring, more lab work, more 
rehab, etc.  When these conditions become excessive, Grouper would then select the 
“major complications or comorbidities” or “MCC” code.  Not all MS-DRG codes have 
all levels of CC/MCC.  Some MS-DRGs differentiate only the most complicated 
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conditions from the rest, and others only the base condition and the rest.  These are 
accomplished with the “w/o CC”, “w/o MCC”, and “w/o CC/MCC” codes. 
Table 4 below shows how CC and MCC modify the MS-DRG.  Complicated peptic 
ulcers have three flavors: MCC, CC, or neither.  Uncomplicated peptic ulcers only come 
in two flavors: MCC or not MCC, which results in the question, how can an 
uncomplicated peptic ulcer have major complicating conditions?  The answer is that the 
ulcer itself is uncomplicated, but the patient’s other conditions would impact treatment 
enough to a) increase the amount of care needed as denoted by “with MCC” severity 
level, or b) not interfere with the ulcer’s treatment denoted by “without MCC” severity 
level. 
Table 4.  Sample MS-DRG definitions illustrating how the severity designator works. 
MS-DRG 
Number Description Severity 
380 Complicated Peptic Ulcer With MCC 
381 Complicated Peptic Ulcer With CC 
382 Complicated Peptic Ulcer Without CC/MCC 
383 Uncomplicated Peptic Ulcer With MCC 
384 Uncomplicated Peptic Ulcer Without MCC 
 
CMS reimburses providers at higher rates for difficult-to-treat patients compared to 
the standard cases.  All incoming claims are assigned an MS-DRG code using a program 
called Grouper, a CMS software product available for purchase designed for hospital 
billing departments to help prepare administrative data for submission to CMS[24].  It 
reads all of the diagnosis and all of the procedures plus additional information to 
determine the appropriate MS-DRG, severity, and ultimately the reimbursement dollar 
amount for that claim.   
1.3.3.3 Define	  POA	  Indicators	  for	  each	  Secondary	  Diagnosis	  
The administrative claims data format circa 2005 was not adequate to handle the 
burden of tracking HAC conditions, nor were the proposed DRG modifications.  It is this 
ability to add complications which gives CMS the mechanism by which to react to 
complicating conditions caused by a hospital’s poor care.  But, there is one additional 
piece of information needed to prevent reimbursement for HACs: Did the patient have 
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the listed diagnosis at the time the patient was admitted to the hospital?  If so, then 
Grouper would classify the claim as it always had.  If not, Grouper would limit 
reimbursement to the base MS-DRG amount only.  This distinction was not possible to 
derive from existing administrative claims data prior to 2007Q4.  CMS defined the POA 
indicator flags as seen in Table 5.  On an administrative claim, if a HAC condition exists 
as one of the diagnosis fields, then each diagnosis must be accompanied by a POA flag.  
If no HAC condition exists in the diagnosis fields, POA flags need not be reported (POA 
field may be left blank on administrative claim). 
Table 5.  POA indicator flags. 
POA 
Flag Definition 
CMS Payment for CC/MCC DRG 
if HAC condition present 
Y Yes.  Present at the time of inpatient admission. Yes 
N No.  Not present at the time of inpatient admission. No 
U Unknown.  The documentation is insufficient to determine if the 
condition was present at the time of inpatient admission.  This 
indicator will be treated the same as ‘N’. 
No 
W Clinically Undetermined.  Unable to clinically determine whether the 
condition was present at the time of inpatient admission.  This 
indicator will be treated the same as ‘Y’. 
Yes 
1 Unreported/Not used.  Exempt from POA reporting. Yes 
blank If no HAC condition present, no POA flags are required. NA 
 
The DRA Section 5001(c) mandates HAC/POA changes be phased in beginning with 
2007Q4 as the date when hospitals would need to start reporting POA indicators with 
their administrative claims data, priming the pump as it were to get the kinks worked out 
of the system.  Starting in 2008Q4, CMS would start using this HAC/POA data to limit 
reimbursements for bad care.  Since the initial definition in 2007Q4, ‘1’ and ‘blank’ 
indicator flags had been phased out as valid POA options effective as of 01-Jan-2010. 
[25]  
Adding HACs into the MS-DRG system results in reduced reimbursement to the base 
level for claims containing a HAC not POA.  Any HAC complication caused by the 
provider is not reimbursed, and is therefore the provider’s burden.  Figure 6 illustrates the 
nuance of MS-DRG reimbursement flow when HACs are involved [26]. 
The DRA Section 5001(c) limits CMS in the following ways: First, only acute care 
hospitals and providers participating in the IPPS need identify secondary diagnosis as 
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being POA for each secondary condition identified on their submitted administrative 
claims.  This excludes “Critical Access Hospitals, Rehabilitation Hospitals, Psychiatric 
Hospitals, or any other facility not paid under the Medicare Hospital IPPS”[27]  Only 
these claims will be subject to a reduction in the MS-DRG payment if a HAC condition is 
not POA.   Knowing hospital type and claim payment type will be critical to modeling 
hospital readmissions using POA data because the data does not include all claims nor all 
hospitals. 
 
 
Figure 6.  CMS HAC reimbursement logic. 
 
1.3.4 Significance	  of	  POA	  data	  
CMS monitors the HAC program producing annual reports containing rates, trends, 
costs, etc.[28, 29]  But POA data is new to health care research.  There are 5 years of 
provider experience, 3 years of which is suitable for study.  POA data offers a way to 
distinguish between patient comorbidities and potentially preventable events.[30] This 
added patient complexity may be useful when assessing hospital readmission risk, and 
this data may be available to clinicians before the patient is discharged. 
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During the initial years of the HAC program, strict interpretation of DRA Section 
5001(c) was interpreted by some providers as having to include POA data for all 
secondary diagnoses found on a patient’s administrative claim only when a HAC 
condition was included.  Consequently, many hospitals rarely include POA data.  Other 
providers had a different interpretation and included POA data for all reported secondary 
diagnoses codes even when no HAC condition was included.  Still other providers 
included POA data seemingly at random.    CMS clarified POA use by mandating all 
inpatient providers shall use POA indicators all of the time starting in 2010Q4.  This 
interpretation difference makes early POA data harder to use because of the hit-or-miss 
quality.  Later data can be used to better effect precisely because of the “everyone must 
use it” directive.  Ninety-five percent of all administrative claims are under this guidance.   
1.4 Research	  Goals	  	  
The purpose of this study is to understand and assess the usefulness of POA 
indicators as a potential hospital readmissions predictor.  Readmissions are a function of 
the patient’s disease state, comorbidities, and demographics.  They are also a function of 
hospital care, principal diagnosis, procedure timeliness and execution.  Further still, 
readmission can be influenced by the community: the type of post-acute care available 
and general community mores toward health care in general.  Many of these factors are 
not in the hospital’s control.  POA is data captured at time of care and is currently not 
used as a predictor by CMS, perhaps because the data is relatively new and unknown, 
perhaps because of questions about the existing readmission model getting clouded by 
additional data.  This study will focus on POA use to establish whether or not it would be 
a useful as a predictor for readmission. 
A Medicare 5% inpatient Limited Data Set (LDS) for the period between 2007Q4 and 
2011Q4 contains approximately 2.8M administrative claims records.  One POA flag per 
secondary diagnosis field on each administrative claim yields ~15,000,000 pieces of data 
for those years.  This is information particular to a patient’s hospital visit that can 
potentially give new insight as to the patient state at hospital admission, information 
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previously unavailable.  That patient state may have some correlation to hospital 
readmission.   
Within that same set of claims, approximately 20% of claims, or 500,000 records, 
represent 30-day hospital readmissions. Also within that same set of claims <7%, 
200,000 records, contain HAC conditions where POA=yes (patient admitted with 
condition), and of those records only ~3100 claims contains HAC conditions where 
POA=no (patient acquired condition after admission to hospital).  Because the 
HAC/POA=no segment is so small, HACs will not be used in this study. 
1.5 Research	  Question	  
POA indicators are new to the health research community.  To date, there have been 
relatively few studies using POA indicators not involving HAC codes.  Given the large 
amount of data and the limited POA indicator analysis, a large number of potential 
research questions could be investigated.  The purpose of this study is to understand the 
relationship, if any, between POA and hospital readmission.  I selected one question upon 
which to focus this effort.   
Would POA indicators be a useful set of data to include when modeling hospital 
readmissions?   
Hospital readmissions is a significant topic because of new laws. CMS, providers, 
private insurers, policy researchers, etc. are focusing on readmissions right now.  POA 
data is relatively new and unstudied, it is national in scope, it is readily available within 
administrative claims data, and it captures patient state during a hospital stay in a way 
that no other administrative data can.  It appears logical to combine POA with 
readmissions. 
1.6 Research	  Database	  Process	  Overview	  
I have developed a data mining study investigating POA indicators for non-HAC 
administrative claims.  To adequately study the POA indicators, it was necessary to 
understand the data and its relationships at a sufficiently deep level.  Complicating this 
mission was the general form of the raw data itself.  Creating a normalized research data 
  
 26 
mining database solved the learning issue and the raw data issue as described in section 
3.1 Data Mining.  Index and readmission claims were then identified.  A standard data set 
was then extracted for three conditions of interest: AMI, HF, PN. Once this step was 
completed, a base statistical readmission model using logistic regression was developed 
using extracted data.  This base logistic regression model was extended to include several 
POA variables and compared to the base model.   
1.7 Rationale	  and	  Significance	  
The HAC/POA program is a relatively new program requiring providers to submit 
new data to CMS.  This data is national in representing a huge injection of data into the 
claims system.  For 2011, there are 12.4M claim records with ~10 POA indicators per 
claim or 123M new pieces of data.  This study is significant in that: 
• This is new data (< 5 years old). 
• It is available nationally. 
• It is available across most providers (short-term & IPPS). 
• It is a significant volume of data. 
• < 200 articles refer to HAC/POA data. 
• Previous incident rates relied upon estimating harm or complications; now there 
is a direct way to measure. 
Significance: what difference does this study make? 
• This is research: adding to knowledge by investigating new data. 
• Other researchers should know if these POA flags are useful or not within their 
models. 
• This is a first attempt to categorize POA usefulness. 
• Are there any potential HAC conditions present within the data? 
This remainder of this research study contains the following chapters: 
• Chapter 2 Literature Review contains a discussion of what has been done with 
POA indicators by researchers thus far.  A number of examples were selected, 
and brief synopses presented as representative of different types of use. 
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• Chapter 3 Methodology frames the research study by defining data mining 
stages concluding with sections describing statistical approach and data 
necessary to test the research hypothesis. 
• Chapter 4 Presents results of base hospital readmission model, POA 
characterization, and hypothesis tests. 
• Chapter 5 Conclusions presents the usefulness along with implications of the 
research. 
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2 Literature	  Review	  
Contains a discussion of what has been done with POA indicators by researchers 
thus far.  A number of examples were selected, and brief synopses presented as 
representative of different types of use. 
2.1 Purpose	  
The significance for investigating POA indicators is to find alternate uses, understand 
how well POA indicators worked to fulfill study goals, and develop a set of POA uses 
this study could implement as statistical variables.   
This section presents a systematic analysis of published literature surrounding HACs 
and POA indicators.  As the data is managed by a U.S. government agency, many of the 
primary sources searched were other U.S. Government agencies, publications, reports, 
and congressional records, or contractors working for the aforementioned.  Search 
sources include CMS, National Institutes of Health (NIH), PubMed, Google Scholar, 
Health Information Management Systems Society (HIMSS), and the American Medical 
Informatics Association.   
2.2 POA	  Review	  	  
POA data has only existed from 2007 onward, and consequently the effective date 
range is limited.  Hospital readmissions as a topic, however, has been studied for a 
decades.  PubMed has references from 1956.  It is impractical and unreasonable to review 
the entire history of hospital readmission starting from that point.  A more reasonable 
date is the point is the timeframe of the ACA’s Medicare Hospital Readmission 
Reduction Program (ACA passage 23-Mar-2010, HRRP effective 01-Oct-2013).  It is 
during this timeframe when a national methodology was developed.  Because this thesis 
is interested in the modeling aspects, 2010 was selected as the early date cutoff for this 
literature search.  POA data is also U.S. health care system specific, so only U.S. 
publications were targeted. 
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The purpose of POA indicators in administrative claims data is to act in concert with 
ICD-9-CM codes to identify HACs, by definition.  Consequently, the search terms 
“hospital acquired condition” and “HAC” along with “present-on-admission” and “POA” 
have explicit connotations on their own but also associations between them.  
“HAC/POA” are often found together under the CMS name for the program, in 
publications describing never-event evolution, and in hospital quality brochures for 
patients, which were removed from further consideration.  When conducting this 
literature search, I started my search with “HAC” and expanded from there toward 
“POA”.  This process enabled me to make note of how the given study used POA data.   
The research question limits the literature search to secondary uses of POA data.  Any 
information in the literature consistent with that goal was included.  If a study 
concentrated upon existing HACs (incident rates, trends, etc.) more so than using POA 
data in a new manner, I filtered it out as not relevant to this study.  Any public-relation-
oriented or marketing-oriented material, I filtered out of this study.  There were a small 
number of technical publications targeting Information Technology (IT) personnel which 
aimed at clarifying data formats, expectations, and timelines, how to prepare and submit 
administrative claims, etc.  These I also filtered out.  The HAC/POA program is evolving.  
In my search, I found minutes from various committees describing pros and cons of 
splitting an ICD-9-CM code to better track an existing HAC, to track potential HACs, 
split or join MS-DRG by CC/MCC codes to differentiate complications from potential 
HACs, etc., and I also filtered these out.   
It is also worth noting an absence of studies.  Using “POA” and “readmission, “re-
hospitalization,” “30-day readmission,” and a few addition terms resulted in zero search 
results.  The combination of “present-on-admission” and “readmission” resulted in one 
study using the English phrase “present-on-admission,” but not the meaning 
“administrative data fields called ‘present-on-admission’.”  All told, 68 search results 
were examined resulting in the immediate culling of half the entries because they focused 
primarily on HACs and not secondary uses of POA.  Of the remainder, I reviewed all 
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abstracts.  I constructed a list of 23 usable search results for full reading resulting in the 
information presented in this study.   
Having read each of the final search result documents, eleven investigations were not 
useful for this study and were omitted. The remaining twelve studies can be categorized 
based upon usefulness to this study by grouping them according to how and what data 
were investigated:   
Hospital POA Documentation Practices:  Five studies tried different approaches to 
increase POA reporting accuracy. 
The Yes/No Nature of POA Data:  Four studies were found using POA data to 
track specific disease states within a hospital setting.   
Groups of ICD-9 Codes and POA Data:  Three studies aggregated groups of ICD-
9 codes and combined them with POA data to form downstream quality measures. 
These categories are presented below, each detailing two studies in order to highlight 
POA usage within their category.  A brief discussion of each category follows this 
section. 
2.3 POA	  Data	  Studies	  
What are possible secondary uses of this new data?  Literally, secondary use means 
for some purpose not originally intended.  Because HAC and POA are already connected, 
secondary use here could mean a) HACs without POA (which is not possible given the 
technical definition of HAC as being an instance of a select ICD-9-CM code coupled 
with a valid POA indicator), or b) POA without HAC.  It is this second option which I 
follow now.  This subsection highlights articles found while conducting this literature 
search.  Each represents a number of similar articles, and each comes at the POA 
indicator usage from a different aspect.  It is these differences which are interesting.  
Each subsection below answers the question “how do researchers use POA indicators 
today?” 
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2.3.1 Hospital	  POA	  Documentation	  Practices	  
The following sections contain two study examples targeting the increased accuracy 
of POA reporting within a given hospital.  Both studies restrict themselves to pressure 
ulcer documentation for the purpose of ensuring enough documentation gets into the 
medical record to clearly make the assessment of POA=yes or POA=no.  This situation is 
intriguing as it represents a potential point of differentiation between hospitals: how well 
different providers document POA data. 
2.3.1.1 Using	  POA	  Data	  in	  a	  Clinical	  Decision	  Support	  System	  
Are providers supplying enough documentation to make a determination of POA=yes 
within their Electronic Medical Record (EMR)?  This question is of interest for two 
reasons:  
• As a point of policy, providers will not be reimbursed if there is insufficient 
documentation to show POA=yes, the patient had the condition when they were 
admitted. 
• A provider’s POA rates may vary from that of it’s neighbors because of its 
documentation practices.   
Several studies examine an attempt to reduce HAC rates by adding Clinical Decision 
Support (CDS) mechanisms utilized by nurses at admission time.  In several instances, 
CDS was inserted into the EMR process and workflow to check for and document 
conditions found on the patient at admission, providing enough information within the 
clinical record to make a determination of POA status for the administrative claim record.  
One such study, by C. Rodgers, titled “Improving Processes to Capture Present-on-
Admission Pressure Ulcers” [31], targets pressure ulcer rates.  The author notes that after 
several years in operation, the HAC/POA program and its implications are having an 
effect on providers. 
“Even if the PrU [pressure ulcer] was present-on-admission (POA) but not documented, it is 
considered as a hospital-acquired condition (HAC) and not reimbursable. The loss of repayment 
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for HACs, such as Stages III and IV PrUs, increases the importance of having an accurate 
process to identify and document PrUs that are POA.” 
 
The medical record must contain enough documentation to show POA=yes.  HAC/POA 
is based on the standard-of-care guidelines.  Hospital staff may not have training to 
differentiate “between PrU Stages I and II and maceration-associated skin damage 
(MASD) or deep tissue injury (DTI)” – different conditions contributing to false positive 
POA condition when one is not present.   
This article clearly shows this provider understands the consequences of not gathering 
enough information to show POA=yes.  The author describes a potential solution to 
adequately checking for pressure ulcers at admission time via a CDS approach.  Within 
the admission workflow, nurses enter patient information and are prompted to check for 
pressure ulcers explicitly.   
2.3.1.2 Using	  POA	  Data	  in	  Terminology,	  Assessment,	  and	  Tracking	  
“New opportunities to improve pressure ulcer prevention and treatment: implications 
of the CMS inpatient hospital care Present on Admission (POA) indicators/hospital-
acquired conditions (HAC) policy. A consensus paper from the International Expert 
Wound Care Advisory Panel,” [32] is another study of interest, which used POA 
indicators not as the source of the information, but as the end.  In FY07, CMS reported 
~260,000 cases of pressure ulcers they consider to be preventable.  The authors conduct 
an informal study to investigate pressure ulcer stage definitions and how those definitions 
are used by clinicians to document POA.  They find raising awareness is not enough to 
change pressure ulcer EMR documentation.  They find with additional education, nurses 
and admitting physicians could be given a framework for incorporating pressure ulcer 
detections, along with daily inspection and information capture.  This additional attention 
can significantly lower pressure ulcer incidence rates.  This change involves shifting the 
documentation from the nurses who usually deal with skin issues to the admitting 
physician who is in charge of the patient’s care.  This shift raises the likelihood that 
enough documentation will make it into the medical record for the purpose of indicating 
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POA=yes.  A consequence of this is better attention toward skin management and 
lowering of hospital acquisition.   
This change is different from the pressure ulcer CDS in that it isn’t throwing 
“technology to the rescue” solutions at the problem.  It is providing the education to the 
people doing the work about the quality of care, total cost, and quality-reporting HAC 
aspects of pressure ulcers.  Education in combination with a workflow framework allows 
initial assessment to flow into continued monitoring under a prevention strategy that 
results in the observed reduction of preventable pressure ulcers.   
2.3.2 The	  Yes/No	  Nature	  of	  POA	  Data	  
These next studies illustrate an interesting point: one needs to understand both the 
nature of the POA indicator and the ICD-9 code for which it goes.  The first is a POA 
success story showing that hospitals are not the source of Adverse Drug Events (ADEs) 
but are downstream from the event based upon the POA=yes indicators.  The second 
study urges caution when combing POA data with certain day-surgery procedures, as all 
complications from them will be marked as POA=yes even though the complications 
occurred after the surgery. 
2.3.2.1 Using	  POA	  Data	  to	  Monitor	  Drug-­‐Usage	  Events	  
An AHRQ study titled “Origin of Adverse Drug Events (ADE) in U.S. Hospitals,” 
[33] used the 2011 Healthcare Cost and Utilization Project (HCUP) data from 32 states.  
It also used POA indicators along with ICD-9-CM codes to classify within the Medicare 
system.  By FDA regulation, ADE data flows to the FDA via drug manufacturers and not 
via hospitals.  The authors use hospital visit as their unit of study.  POA is used directly 
to tally ADE events.  The authors had access to an entire year’s worth of data, and report 
on a census not a sampling.  They list actual ADE rates by using a subset of ICD-9-CM 
codes found in ~20M claim records.  Without considering POA, ADE rates could be seen 
as hospital deficiency: poor oversight, lack of clinician training, etc.  Once POA 
indicators are included however, the results show that “across all causes of adverse drug 
events, there were three times as many ADEs that were present-on-admission than 
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originated during the stay.”  POA data refutes the claim of poor hospital quality when it 
comes to drug events. 
2.3.2.2 Using	  POA	  Data	  to	  Monitor	  Hospital	  Procedural	  Effectiveness	  
Instead of targeting a hospital’s effectiveness, another study utilizing POA indicators 
focused on downstream events from Carotid Angioplasty and Stenting (CAS).[34]  The 
authors propose a study to gage procedure complications by checking for secondary 
diagnosis conditions using POA indicators as a guide to determining if the conditions 
existed before or after the surgery.  They study data from California for years 2005-2008, 
New York covering 2008, and New Jersey covering 2008.  First, the authors define a set 
of ICD-9-CM procedure codes as targets, and then define a second set of codes as 
potential complications resulting from the procedures.  They construct three statistical 
models one of which uses POA as a model parameter.  The authors find conflicting 
outcomes between their models and illustrate with an example of stroke.   
One identified side effect of Carotid Endarterectomy (CEA) and CAS is stroke.  Half 
of the patients under study had “stroke POA=yes.”  To the model not using POA 
indicators, this presents an underrepresentation of hospital effectiveness by lumping all 
strokes as either “hospital acquired” or “the patient has a stroke before admission.”  
However, patients could have a stroke with these procedures and have this fact go 
undocumented because of the administrative claims data limitation in recording such 
events: “patient had a stroke condition? Yes.  Was there a stroke condition present-on-
admission? Yes.”   
The authors make three additional points about the inherent difficulties of capturing 
POA documentation.  First, CEA and CAS procedures are most likely to be same-day 
admission procedures.  Any potential complications are therefore likely to be coded as 
POA=yes.  Second, there is significant miscoding within the POA data the authors 
examined.  It was their conclusion POA data miscoding represented poor classification 
and no evidence was seen to conclude it was a reimbursement gaming activity.  Third, the 
ICD-9-CM diagnosis codes are not capable of indicating intraoperative or postoperative, 
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nor where complications such as stroke occurred.  This last set of limitations are 
addressed in part with the release of ICD-10 coding.   
2.3.3 Groups	  of	  ICD-­‐9	  Codes	  and	  POA	  Data	  
Two example studies combine groups of ICD-9 data with POA data to draw forward 
an inference that POA=no is a sign of some patient complications.   In the first study, 
ICD-9 codes for sepsis were expanded and grouped by POA to track post-surgery 
infections.  The second study is similar to the first mechanically, but significantly 
expanded to include a wide array of groups derived via the claims data itself.  These 
represent complication to patient stay and may also be linked to readmission. 
2.3.3.1 Using	  POA	  Data	  to	  Monitor	  Infection	  Control	  Programs	  
There are several studies which utilize POA codes as part of a statistical modeling 
effort.  “Post-admission Sepsis as a Screen for Quality Problems: A Case-Control Study,” 
[35] from Nov-2013 focuses estimating a hospital’s infection control program by 
examining administrative claims for sepsis.  There are five to six ICD-9-CM diagnosis 
codes for sepsis, depending upon ICD-9 version.  The authors identify an additional 20 
ICD-9-CM diagnosis codes associated with sepsis.  Their case-control study attempts to 
identify links between hospital quality of care practices (as identified by these 20 
secondary conditions) and hospital acquired sepsis cases by utilizing the POA=no 
indicators within the administrative claims data.  The study’s premise predicts a 
significant rise in the secondary sepsis conditions at hospitals having poor infection 
screening programs. Their method combines secondary conditions with POA indicators 
to form a quality measure proxy used to screen in-hospital infections.  This study used 
baseline data from New York state hospitals starting with years just prior to the CMS 
mandate, New York being a leader in the early adoption of POA indicators implemented 
their program in the 1990s. 
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2.3.3.2 Using	  POA	  Data	  to	  Monitor	  Hospital-­‐wide	  Patient	  Complications	  
A significant study utilized POA indicators in a non-HAC setting attempts to identify 
Potential Inpatient Conditions (PICs) as the next circle out from HACs.  In “Identifying 
Hospital-Wide Harm: A Set of ICD-9-CM-Coded Conditions Associated With Increased 
Cost, Length of Stay, and Risk of Mortality,”[36] the authors note the incidence of HAC 
conditions constitute a small number of claims, and therefore non-HACs contain the 
remainder of claims essentially in a category called “other.”  They propose a method to 
divide these “other” claims into PICs and “other” by defining a methodology leading to a 
set of PICs.  They further describe how PICs could be used to improve health care.  The 
study has two parts: forming PICs, and correlating PICs with other claim attributes. 
Forming PICs: Central to the methodology is the use of POA indicators.  Using a 
national data set covering 2008Q4 through 2010Q3, the authors partition claims into 32 
service lines: gastroenterology, cardiology, etc., based on MS-DRG codes.  These groups 
are then sorted into 4 larger groups.  For each group, they create tallies of all ICD-9-CM 
diagnosis codes having POA=no status.  The results are sorted by tally and significant 
ICD-9-CM codes were added to clusters by manual review.   
Correlating PICs:  500,000 national claim records between 2008Q4 and 2010Q3 are 
used to link the cluster with length of stay (LOS), mortality, and cost.  The authors 
identify 86 conditions they consider “high-impact conditions” associated with real 
phenomena at statistically significant rates.  The study does not go into causality: “longer 
LOS might increase the risk for pressure ulcers rather than the pressure ulcers driving the 
longer LOS.”  But, PICs can indicate a hospital’s rates above/below a given quality 
threshold.  Within the PIC study, PIC attributes are correlated to a single administrative 
event.  No hospital readmission modeling is conducted.   
2.4 Summary	  
I have examined how researchers use POA data for secondary purposes.  The 
previous section characterizes three different categories of POA data usage relevant to 
this study.  Overall, the number of studies conducted using POA data is relatively small 
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due in part to the relative age of the HAC/POA program and the limited amount of data 
available, making it a harder subject to study.  It is for this reason that a limited number 
of studies makes this a fresh area for research. 
From using CDS to assist with POA accuracy to shifting documentation practices 
from nurses to doctors when recording HAC/POA data, comes the idea that a provider’s 
POA rates may vary from its peers because of a hospital’s documentation practices, 
training, support technology, or staff training.  It may be possible to find a way to create a 
POA metric based at the hospital level that could be tracked over time.   
From the ADE and procedural effectiveness study, it appears POA data has a 
personality based upon its associated ICD-9 code.  Just because POA is used, doesn’t 
mean it represents the same thing for different diseases.  There is a nuance to POA data.  
Defining POA metrics and applying them over a wide array of conditions may not 
produce consistent results.  Disease or procedure categories play a role in POA 
characteristics. 
From the infection control and potential inpatient condition studies, the idea that POA 
data can cluster around certain diseases, codes, or procedures makes it possible to link 
more than one code or group together, such as AMI, HF, or PN.   
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3 Methodology	  
Frames the research study by defining data mining stages, concluding with sections 
describing statistical approach and data necessary to test the research hypothesis. 
 
3.1 Data	  Mining	  
Under more normal analytic circumstances, raw administrative claims files would be 
loaded directly into a statistical engine for analysis.  Administrative claims files are 
usually received as one large file per calendar year, each file containing between 600,000 
and 900,000 rows of data for a 5% random sample.  In this case, I have graciously been 
granted access to Medicare’s inpatient LDS files covering years 2007 through 2011 via 
the University Of Minnesota Carlson School Of Management’s Medical Industry 
Leadership Institute (MILI).  These files together comprise a total of ~2.9M rows of 
administrative inpatient claims data.  However, each raw data file has a different number 
of columns, different column names for the same data field, different column order, 
different data encodings for the a column’s year-to-year content, in addition to anywhere 
from dozens to hundreds of superfluous columns. 
Raw data could not simply be loaded into a statistical package directly and consumed.  
It required additional processing to normalize and standardize column data.  Any 
normalization process is time-consuming and potentially error prone.  To prevent 
generating inferences upon questionable data, I chose to build a data mining database by 
writing my own custom database build and verification tools.  Building a database is the 
first of three steps needed to build a data mining capability.  These steps include: 
1. Assembling the Research Database.  
I built a data mining database containing the claims and mashed them with 
DRG definitions, ICD-9-CM definitions, U.S. census data, Research Data 
Assistance Center (ResDAC) names and codes with field information, and 
CMS hospital data.    Data cleansing is another activity completed with this 
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step.  I validated all fields against expected values.  By completing this step, I 
gained a base understanding of the exposed relationships within the data. 
2. Creating Experimental Data Sets.   
From this source database above, I extracted study sets for analysis.  Data 
mining is a process of learning and knowledge building.  It is very much an a 
priori method of learning; often where the ends are not always clear from the 
start.  The central output from this activity gave me a base understanding of 
the hidden relationships within the data. 
3. Defining Statistical Models.   
I utilized logistic regression to explore interactions and relationships among 
data set variables.   
I expand and explain each of these steps in greater detail below.   
This approach controls for variation of data formats and ensures consistent definition 
of data across the study years.  This approach also allows for flexibility to explore 
relationships within the data by using varied tools (spreadsheet, pivot tables, custom 
visualization, statistical) without committing to a particular format.  This approach also 
allows for learning and extending of relationships to include new data.  Finally, this 
approach allows imposing statistical rigor to questions of interest, ultimately including 
the research questions. 
3.2 Assembling	  the	  Research	  Database	  
I chose MySQL [37] along with its associated tools as my database engine of choice.  
Within MySQL Workbench, I designed a snowflake schema within which I could 
maintain the claims records and layer external definitions and additional data (Figure 7).  
Administrative claims act as the central fact table.  Surrounding the fact table are 
dimension tables, which are normalized and indexed data from the central fact table.  
These appear as veins of the snowflake radiating away from the center.  A dimension 
example is the DRG table.  The database build process loads all known MS-DRGs and 
crosslinks them to the central fact table.  By this method, all central fact table DRGs are 
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validated against the known list.  In addition, query time in either direction for example, 
DRG-to-central fact or central fact-to-DRG, is reduced by removing DRG information 
and replacing it with database keys.   
 
 
Figure 7.  Research database schema.   
 
Dimension tables have two types: normalized dimension tables used to uniquely 
identify a given dimension, and cross-reference tables, used to increase join efficiency 
between central fact and dimension data.  An example of the latter is the “icd_codes” 
table and the central fact table “claims”.  In this case, I introduce an xref table to cross 
link ICD9 codes to rows in the fact table which results in vastly reduced query times at a 
cost of additional SQL code.  Xref tables are also beneficial when, as in this case, there 
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are multiple sources for the data:  ICD-9-CM definitions are available from multiple 
sources, and the administrative claims data is available from CMS.  The integrity of each 
table can be validated independently from the others because they are only connected at 
the xref table. 
Dimension tables ebb and flow as different questions arise.  The schema presented in 
Figure 7 is an example of a point-in-time snapshot of the research schema.  It is a 
conceptual representation showing tables as the colored boxes and connections between 
them indicating relationships.  The symbols on the lines next to the tables indicate 
cardinality of the relationship.  Provider and Claims, for example, contains two small 
lines next to Providers meaning “every claim record has one and only 1 provider 
associated with it.” There is a relationship in the reverse direction as well indicated by 
what has become known as “crow’s foot” notation.  The reverse relation indicates “every 
provider is associated with one or more claims records.”  These concepts are codified in 
the database itself.  Note also “claim_xref_4b_testing” and “hac_xref_4b”  These tables 
are examples of the iterative analysis process (only two were shown for brevity).  Table 
contents and relationships change as knowledge expands and as wider dimensions are 
combined into the mix.  From these tables, extracts are drawn and fed into R [38] for 
visualizations, first-order statistics, and eventual inference.  
The input data or base data used for this research comes from many sources.  Within 
this section, I identify each data source, versions if applicable, relevant fields within the 
source and any additional notes. 
3.2.1 Administrative	  Claims	  Data	  
This study used Medicare’s administrative inpatient claims data, 5% LDS spanning 
the calendar the years 2007 through 2011; five years in total.  POA indicators and MS-
DRGs along with main ICD-9-CM diagnosis codes did not exist before 2007Q4, and so I 
omitted it from the research database.  This data is de-identified.  It contains no patient-
identifiable data, all locations are limited to state level and 3-digit zip code (if the zip 
code is present at all), and no physician identifiers are present.  It does contain the claim’s 
true THRU_DT values, making it possible to construct an accurate inpatient history of 
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events.  This is different than the usual LDS files where dates are truncated to the year 
and quarter.   
The following fields were used within this study.  Their definitions can be found in 
ResDAC “LDS Inpatient SNF [Skilled Nursing Facility] Claim Record Data 
Dictionary.”[39] 
3.2.1.1 Coded	  Fields	  
Administrative claims data contains numerous fields whose values are keys, the 
actual meaning of which could be simple enough to be defined in the LDS Data 
Dictionary.  For example, GNDR_CD contains the code definitions: “1=Male, 2=Female, 
or 0=Unknown.”  When these codes represent data shared across several CMS databases, 
the definitions are maintained elsewhere; ICD-9-CM definitions are not defined within 
the data dictionary, but are available from the CMS web site.  Still other fields have 
definitions maintained by ResDAC, “a CMS contractor that provides free assistance to 
academic, government and non-profit researchers interested in using Medicare and/or 
Medicaid data for their research.” [40]  These field definitions or decodes are available 
per field by using the identified table name in the LDS Data Dictionary for the particular 
field. 
All administrative clams fields used in the research database have definitions taken 
from the ResDAC web site.  I saved these definitions into individual <field>.raw text 
files, where “field” is represents names such as “bene_gndr”, “fac_type”, or “ptntstus”.  I 
manually scanned the raw text for junk, invalid characters, confusing definition strings, 
historical encodings, notes, sub-types based on other fields not present in the given 
definition file, etc.  Then I manually coerced these files into <field>.data file; a form 
capable of being imported directly into a database or into R.  I stored all codes and 
definitions in a table called names_codes along with a category identifying the field to 
which they belong.  I do not show this table in Figure 7 above because it has so many 
relationship links it obscures the snowflake design. 
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3.2.1.2 ICD-­‐9-­‐CM	  Codes	  and	  Definitions	  
The admitting diagnosis field (AD_DGNS), primary diagnosis field (PDGNS_CD) 
and ten claim diagnoses codes (DGNSCDx) contain ICD-9-CM diagnoses codes.  A 
claim’s six procedures codes (PRCDRCDx) contain treatments performed on the 
beneficiary.  These codes may vary slightly year to year as new conditions or treatments 
become known and as old ones become disused.  ICD-9-CM codes are reviewed 
periodically and updated on CMS’s fiscal year, which starts each 01-Oct.  I loaded each 
ICD-9-CM code set for the time span 2007Q4 through 2011Q3 into a separate table.  I 
assigned version numbers to each code for back-checking and code normalization.  All 
ICD-9-CM diagnosis and procedure codes I normalized to a common value in order to 
allow year-to-year comparisons using code and definition files provided by CMS.[41]   
3.2.1.3 Claim	  POA	  Flags	  
The ten POA fields (CLMPOAx) accompany the ten diagnosis fields (DGNSCDx).  
CMS does not process these fields in any way.  These fields contain raw data from the 
providers.  Consequently, as part of the data loading and validation step, I translated ‘y’ 
values to ‘Y’, etc.  All unknown values I considered invalid and treated as “no data”, 
“null”, or “NA” for statistical purposes. 
3.2.1.4 Beneficiary	  Date	  of	  Birth	  
The beneficiaries in the LDS files used in this study I binned to 5-year values as 
described in the LDS Data Dictionary. 
3.2.1.5 Provider	  ID	  
The provider identification is the institutional provider Medicare certifies to provide 
services to the beneficiary.  The provider ID field within the administrative claims data is 
a non-atomic a 6-character “ID” composed of two parts with up to four meanings:   
• Two character positions encode digits that represent the Social Security 
Administration’s (SSA) state ID code.  (See 3.2.3 State Code Crosswalk File 
below.) 
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• Four character positions uniquely encode a “hospital ID” within the given SSA 
state. 
• The hospital ID is a range of numbers within a series which further classify the 
hospital’s type.  (For example, a hospital ID in the range 0001 to 0879 
identifies a “short-term hospital.”) 
• The hospital ID may have optional character overlays creating an additional 
layer of identification.  (For example, codes ‘E’ and ‘F’ indicate an Emergency 
Hospital, and code ‘M’ indicates a Psychiatric Unit within a Critical Access 
Hospital.) 
I preserved all of these available codes and their meanings within the research 
database. 
3.2.1.6 Claim	  ID	  and	  Beneficiary	  ID	  
The CLAIM_NO field uniquely identifies a single administrative claims record.  The 
BENE_ID field is a de-identified beneficiary ID that has been replaced with a random 
string to prevent re-identification of the patient.  It does, however, allow me to construct a 
patient’s claim history. 
3.2.1.7 Claim	  Through	  Date	  and	  Utilization	  Day	  Count	  
THRU_DT is the last day of a beneficiary’s hospital stay.  UTIL_DAY is a number 
that represents the total number of days the patient remained within the given provider’s 
facility for treatment.  It can be a tricky number to use.  HACs can increase a patient’s 
treatment at an inpatient facility, a side effect of which may be a longer stay in the 
hospital: a higher day-count.  It is also true that longer stays may increase the likelihood 
of a HAC occurring.[42]  Because HACs act as both a cause of longer stays and an effect 
of staying in a hospital longer, it becomes difficult to separate them when examining 
administrative claims data, particularly with a 5% LDS sample.  The patient’s admission 
date is a calculated value: THRU_DT – UTIL_DAY.   Admission date is used to derive 
any days between hospital visits for readmission analysis.   
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3.2.1.8 Financial	  Fields	  
TOT_CHRG represents the provider’s “retail” cost for services supplied to the 
beneficiary.  PMT_AMT is the actual amount CMS paid to the provider.  
BENE_DDCTBL_AMT is the beneficiary’s deductible amount given to the provider.  
Beneficiaries may also have coinsurance with a liability amount: BENE_COIN_LBLTY.  
The following derived fields I use in the research database: 
Patient’s Cost = BENE_COIN_LBLTY + BENE_DDCTBL_AMT 
Amount Allowed = PMT_AMT + Patient’s Cost 
3.2.2 MS-­‐DRGs	  
All administrative claims starting with 2007Q4 have an associated MS-DRG code.  
The MS-DRG codes are available from CMS [43]. This file includes the MS-DRG 
numbers plus their one of 26 Major Diagnostic Category (MDC) codes, a type of either 
“surgery” or “medical”, and a brief description.  Contained within the description string 
is an optional “with/without” “CC/MCC” status indicator, which has been extracted and 
saved for DRG complexity comparisons.  I have linked all of the MS-DRG codes in the 
research database to DRG definitions within this file. 
3.2.3 State	  Code	  Crosswalk	  File	  
The SSA state codes are a 2-digit number linking a 2-character abbreviation and a 
text string representing a U.S. state, a territory, or some other geographic region.  This 
numbering does not match the Federal Information Processing Standard (FIPS) state 
numbering scheme used by the rest of the U.S. government.  To link to U.S. census data, 
I converted the SSA state ID numbers to FIPS state numbers using a crosswalk file. [44]  
I save both the SSA state information and the normalized FIPS standard within the 
research database. 
Because the hospital ID number within a state is also used to encode a hospital type 
by using ranges of hospital ID numbers, some states ran out of space in their numbering 
scheme.  To solve this, SSA created “new” state numbers to preserve the existing hospital 
type encoding at a cost of duplicating state IDs:  for example, Texas uses SSA state IDs 
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45, 67, and 74 while the FIPS system uses only 48.  SSA state 2-digit ID number to FIPS 
state name decodes are available from multiple sources. [45]   
3.2.4 US	  Census	  Population	  Data	  
I added population data available from the US. Census Bureau to the state tables.  
Census data uses the FIPS state and county codes.  I used the crosswalk file to link 
population, demographic, and economic data to the SSA codes for the corresponding 
territory. 
3.2.5 Hospital	  Attributes	  
Basic hospital information is available from CMS via their hospital cost data 
files.[46]  The data available contains hospital name, location, and attributes such as 
number of beds, number of Medicare patients served, and total number of patient 
discharges during the calendar year.  This data is self-reported, compiled annually, and 
may be missing or rounded.  The address information may refer to “head office,” 
“administrative building,” etc., and not the actual hospital location.  Within the hospital 
information, some bed fields were blank and could not then be used for analysis.  They 
represent eight hospital records attached to seventeen administrative claims, and I deem 
them acceptable to omit.  Then, I merged hospital attributes with the administrative 
claims data set via the providers dimension table. 
3.2.6 Data	  Verification	  Checks	  
I programmed all database loading steps to increase reliability and to make iterative 
design changes possible.  The data input process validated each field for unrecognized 
input as it was read from the raw files.  When I discovered such an item, I wrote the file 
name, input line number, database row number, field, and error message to an error table.  
Then I reviewed and corrected these issues as a post-build process.  Items included 
detecting punctuation characters instead of digits.  
I also created a full loop-back check mechanism.  No data was harmed in the making 
of the research database.  Therefore, a given row could be read, reassembled, and 
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compared to the original line from the given file to determine database import process 
integrity.  This process ensures that I did not accidentally transmogrify any data. 
I checked all creation, manipulation, and checking programs, and source data files 
into GIT,[47] a version control program used to facilitate both change tracking to source 
code and correct system versioning across system pieces. 
3.3 Creating	  Experimental	  Data	  Sets	  
3.3.1 POA	  data	  	  
As a reminder, administrative claims in this study are limited to between 0 and 10 
diagnosis codes and corresponding POA indicators.  A POA=no indicates a secondary 
condition that occurred in the hospital after the patient was admitted.  CMS does not filter 
or process these values when assembling LDS files, meaning the POA fields contain 
“raw” entries directly from the providers.  I removed invalid values as described in 
Section 3.2.1.3. 
For the purposes of adjusting reimbursement, CMS equates a POA=u (unknown) 
indicator with a POA=no.  Likewise, they equate a POA=w (cannot make clinical 
determination) with POA=yes.  All of the statistical data sets I created for this study 
follow this rule.   
3.3.2 General	  Techniques	  
The purpose of this study is to understand and assess the usefulness of POA 
indicators as a potential hospital readmissions predictor.  This section describes several 
methods used to explore data, relationships, and form a basis from which statistical 
models may be drawn.   
In most cases, the first step in understanding data is running simple queries against 
the research database.  I formed queries using MySQL Workbench, and revealed first cut 
statistics via simple aggregation.  Once I determined an interesting result set for a query, I 
exported the set into comma-separated value files where the data set can be imported into 
the next tool, typically Excel.  I repeated the process adding additional dimension data 
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such as hospital attributes, patient demographics, and admission quarter or month.  At 
some point, the data set becomes impractical for Excel and the analysis space turns over 
to R, enabling statistical modeling along with more complex visualization. 
Analysis can also extend beyond what a simple SQL statement could provide.  As 
with the change of tools above, there is a data aggregation tool change.  For this research 
project, I have chosen to use Perl [48] to provide all of the data transmogrification and 
programming needs.  I created and validated small sample sets using a county or state as 
an upper limit on size.  Then I checked the extracted sets via summary statistics, charts 
and other visualizations.  I repeated this process to include additional columns making the 
data set richer, or to add more rows including more observations.  With confidence in the 
incremental data, I could draw a complete data set and examine internal data relationships 
in fine detail. 
3.3.3 Exploring	  POA	  Indicators	  via	  Excel	  and	  R	  
Aside from the usual spreadsheet functions such as sum(), mean(), quartile(), which 
are available in SQL or any programming language, Excel has two key features useful for 
analytics: quick charts and pivot tables.  Data visualization is often referred to as 
presentation: the culmination of the analytic process represented in a graphic form.  
Backing up to the initial stages of analysis, this ability of letting the eye consume and 
relate information makes it possible to conduct visual experiments quickly and 
efficiently.  Text and tables of numbers work well for small amounts of data.  Subtleties 
may easily escape the reader.  But a picture has a better chance at conveying a message 
hidden within the data than a large table or block of text.  It is this visual efficiency that 
makes early charting compelling as an analytic tool.   
Excel’s pivot tables extend charting by easily changing variables of interest.  They 
accomplish this by summing and cross-summing data.  For example, converting a list of 
claims records, one can create a pivot using hospitalizations by state and by then by 
month.  The resulting table is now a new way to consider the original data.  It may be 
valuable to look at as is, or by creating a new chart.  Either is appropriate at the initial 
stage of data analysis: generating initial data sets. 
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When an initial data set is determined to have more potential than another set, it is 
useful to have more extensive tools with which to examine the set.  For this extended tool 
set, I have chosen R, a statistical programming language and R Studio, an environment to 
interact with the data.  I can create R scripts to process input data, transforming it for 
detailed analysis using a variety of inference algorithms.  R itself has numerous built-in 
statistical functions just like all the other statistical packages: T-Tests, ANOVA, Chi-
Square, GLM for linear and logistic regression.  R is an open-source system allowing 
users to create and share modules with the R community.  Among these modules are 
newer statistical techniques or visualizations including: ggplot2 and Caret.  The former is 
widely believed to be the standard for R data visualizations and the later contains a best-
of-breed implementation of the Random Forest ensemble machine learning technique.  
3.3.4 Beneficiary	  Hospitalization	  Viewer	  
The next step to understanding administrative claims data is to look beyond the single 
claim and look into individual patient histories.  Several of the studies listed in Section 2 
aggregate data at the hospital level.  Others aggregate data at the state level.  I found a 
need to understand diseases through patients who had them because the disease 
conditions interact with each other.  I created a patient hospitalization viewing tool to 
allow me to see patient history rolled up in an aggregated format.  Of specific interest is 
seeing providers phase in POA reporting from year to year.  Another point of interest is 
seeing a patient’s hospitalizations, their duration and time until the next (Figure 8).  All 
patient identifiable information has been redacted.  HAC conditions are highlighted in 
yellow.  POA=no conditions are highlighted in blue, and days between claims are 
highlighted in green indicating more than 30 days and red indicating less than 30 days.  
Note that this particular patient has AMI and PN primary diagnosis conditions marked by 
‘P’, but also has HF as a secondary condition. 
Just building this tool provided a glimpse of the administrative data researchers may 
not ever get.  It allows claim examination if an individual patient’s disease progresses.  It 
allows seeing downstream complications of various procedures, and allows for assessing 
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how well the 30-day readmission logic seems to be working.  I came back to this tool 
time and time again to understand what data exists and what my tools had implied. 
 
 
Figure 8.  Sample AMI patient viewer output. 
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After working with claims data for a while, it is easy to make the leap from seeing 
this data as “clinical” in nature overlooking its “administrative” aspects.  Under the 
former, one can come to expect the data to be in a certain format, nice and orderly, where 
all data is accurate, complete, without conflicts.  Under the latter, there are changes, 
amendments, refusals; a patient can be seen at multiple hospitals, transferred to long-term 
care and back.  These changes can be seen when looking through individual patient 
histories where they may not be seen through aggregated results or filtered out as 
“outliers.” 
3.3.5 Data	  Exclusion	  Criteria	  
CMS uses AMI, HF, and PN within their hospital readmission evaluation process.  
This study limits itself to these conditions as well.  Three sets of study data need to be 
produced: one for each condition of interest: AMI, HF, and PN.  However, the process of 
establishing readmission requires looking between claims as well as within claims.  Each 
patient’s claim history must be established.  Index events and subsequent readmissions 
must be established, all as described in Section 1.2.2.  CMS describes the process adopted 
by NQF and uses the following conditions to remove certain claims records from 
consideration with identifying potential index claims.  CMS contracted with Yale 
University/Yale-New Haven Hospital-Center for Outcomes Research & Evaluation 
(Yale-CORE) to define preliminary hospital readmission measure methodologies for 
AMI, HF, and PN, publish these measures, solicit comments, and incorporate feedback 
into a final set of measures.[49, 50, 2]  These exclusion criteria are true for all three data 
sets.  These conditions are: 
• Claim not from U.S. state and D.C.  
• Claim not from short-term acute-care hospitals 
• Claim not an IPPS claim type 
• Patient < 65 years old at time admission 
• Patients who die in-hospital 
• Patients who are transferred out for escalated care to other facilities 
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• 30-day exclusion for same diagnosis.  See Figure 5, option 1.  Claim can be an 
index or a readmission, but not both. 
AMI has two additional exclusion criteria: 1) Claims with zero utilization days 
(length of stay) are not considered “valid” AMI conditions.  2) Claims with “staged 
procedures,” where a hospital discharges a patient pending a scheduled procedure, are not 
under a standardized clinical guideline making them difficult to filter in or out.  This 
study uses the first exclusion criteria, but not the second.  HF also has an additional 
exclusion based on a beneficiary’s enrollment in Medicare Part A and Part B.  This study 
does not utilize Part B data, so this criteria will be ignored.   
3.3.6 Data	  Inclusion	  Criteria	  
Once I deemed claims eligible for inclusion in the study, I assigned each claim an 
index and readmission status across all years using methodology defined in Figure 5, 
option 2 (a claim can be either index or readmission or both).  A second pass reduced this 
list to option 1 (a claim can be either index or readmission but not both).  I extracted all 
potential index claims having a primary diagnosis code found in Appendix B – Principal 
Diagnostic Codes for AMI, HF, and PN into one of the three disease data sets.  I used 
these data sets to develop the base statistical hospital readmission model.  I kept any 
claims with incomplete data in the data set and marked the missing information as “null”. 
3.4 Defining	  Statistical	  Models	  
3.4.1 Approach	  
I used logistic regression to evaluate the usefulness of POA data within the hospital 
readmission estimation process.   With regard to hospital readmission modeling in 
combination with the data available for this study, it makes sense to identify a model 
using a minimal set of predictors.  The study’s purpose is to understand the impact of 
incorporating POA data into readmission models, not to create a “new and improved” 
readmission model nor duplicate efforts of Federal agencies.  I deemed it sufficient to 
approximate existing hospital readmission models.  Therefore, I developed one statistical 
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model as a base model representing hospital readmission.  I tested the base model against 
each primary diagnosis condition’s data set varying POA data included and varying 
readmission time period as defined below. 
Hospital readmission periods are defined as: 7 days, 15 days, or 30 days from the 
given claim’s through-date field.  CMS uses 30 days as its standard, which was adopted 
from the NQF 30-day hospital readmission.  MedPAC refers to 7-, 15-, and 30-day 
readmission windows.[8]  See Figure 9.  Seven days was the lowest number I found in 
the literature.  Researchers thought seven days was long enough to capture a reasonable 
proportion of side effects and complications following surgery.  However, seven days is 
not long enough to capture Hospital Acquired Infections (HAIs) adding credibility to 
fifteen days.  Other studies reference thirty days.  I have included all three readmission 
periods because they are all in-use.  The section below describes additional detail about 
the contents of the model, the independent and dependent variable.  
 
 
Figure 9.  Potentially preventable readmissions. 
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3.4.2 Hypotheses,	  POA	  Explanatory	  Variables,	  and	  Final	  Base	  Model	  
The data and methodology describe a base readmission dataset and a repeatable 
method to identify hospital readmissions.  It is upon this work that POA data can be 
incorporated and analyzed.  I now develop the following hypotheses and predictor 
variables:   
 
H1 The presence of POA=no indicators on an administrative claim is a 
predictor of hospital readmission. 
p1 is defined as a dichotomous variable set to 1 if any POA=no indicators 
were found on the administrative claim.   
 
H2 The number of POA=no indicators on an administrative claim is a 
predictor of hospital readmission. 
p2 is defined as the count of the number of POA=no indicators found on 
the given administrative claim.   
 
H3 The rate at which a hospital fills POA fields across all of its 
administrative claims is a predictor of hospital readmission. 
p3 was set as an aggregated variable at the hospital level by counting all 
claims with any POA indicator set on any of its administrative claims.  
Due to the fluctuation in POA adoption, CMS directions or guidance, and 
overall adherence within the early years of the HAC/POA program, I 
divided this variable into rates per hospital per claim year.   
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The predictors p1 and p2 extend the readmission model by adding data richness, 
making the data set wider versus making the data set longer by adding more rows of data 
at the individual claim level.  p3 attempts to use POA adoption rates aggregated at the 
hospital level to add new data to the readmission model as a method to add statistical 
richness.  This rate uses all data available for all of a hospital’s claims, not just subsets 
for individual diagnoses.   
I harvested the following variables from claims, aggregated them, or mashed them 
into the diagnosis condition datasets.  These variables did not vary over the course of 
testing, and provide a reasonable approximation of the CMS data given the limited set 
used for this study.  Combining these variables produces a base hospital readmission 
model. 
B represents a beneficiary matrix containing 5-year binned ages and gender.  I 
included race in the initial estimation model development, but I removed it due to 
sparseness. 
H represents hospital characteristics matrix containing state, number of beds, a 
rural/urban dichotomous variable, and CMS region.  I used state data to compare state-to-
state results.  I dropped CMS regions from the model as they were always statistically 
insignificant. 
S represents a claim severity matrix containing MS-DRG information.  I included this 
information as a way to account for the severity of conditions or of complications at the 
claim level.  There may be some interaction between POA and the severity, but the 
relationship is not causal. 
Y represents the estimation model’s dependent variable of hospital readmission.  I set 
it to 1, indicating the current claim has an associated readmission claim within the 
defined test interval, and I set it to 0 otherwise.  For each patient, I converted the number 
of days between potential index events into a dichotomous readmission variable.  
Estimates having a positive sign indicate increased log odds of readmission within the 
defined test period, and negative estimators indicate a reduced log odds of readmission.   
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Combining all of the predictors produces the following hospital readmission model: 
 
Ynbcht   =  β0 + β1Bb + β2Pcht + β3Hht + β4Sct + β5Cc + εc 
 
Such that the variables represent: 
Ynbcht dependent variable: 1 if administrative claim is a readmission within n days of 
index discharge, where n={7, 15, or 30}; or 0 otherwise 
β0 model intercept 
B  beneficiary matrix:  age, gender, race, urban/rural, state, etc. 
C  administrative claim:  utilization days, cost, MS-DRG, etc. 
P POA data (see above) 
H  hospital attributes 
S  severity measure for a given year 
ε  error term 
 
Where the subscripts represent: 
b beneficiary subscript 
c claim subscript 
h hospital subscript 
t time (year) subscript 
 
This model was tested using three datasets, one for each AMI, HF, and PN.  Each 
model tested hospital readmission at three different readmission periods: 7-day, 15-day, 
and 30-day.  Each model tested each hypothesis, and so resulted in  
  3 conditions 
  3 readmission periods 
 x  3 POA variables 
  27 total models 
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4 Results	  
Presents results of base hospital readmission model, POA characterization, and 
hypotheses tests. 
 
4.1 Descriptive	  Statistics	  for	  Hospital	  Readmission	  
The purpose of this section is to establish the equivalence of this study’s hospital 
readmission model to other readmission studies. 
4.1.1 Ability	  to	  Identify	  Hospital	  Readmissions	  	  
I filtered each administrative claim for eligibility in readmission processing to best 
match the CMS criteria implementation given both the limitation of this study’s input 
dataset and the limitation of the POA data.  As seen in Table 6 below, I removed about 
half of available claims from the study for one or more reasons. 
Table 6.  Summary of ineligible claims 
Exclusion Criteria (these categories overlap) Claim Count 
Claim 
Percent 
Claim from cancer hospital 5677 0.20% 
Non-payment, zero claims 241 0.01% 
Not a US state or DC 9933 0.35% 
Not main hospital (psych or rehab units) 120962 4.25% 
Not IPPS claim 166016 5.83% 
Not short-term (acute care) hospital claim 203146 7.14% 
Patient <65 or age unknown 778864 27.36% 
Patient died or still a patient (intermediate claim) 102271 3.59% 
Zero-day claim or delta (claim-to-claim) 181110 6.36% 
Claim replacement of previous claim 406310 14.27% 
   
Claims excluded 1417117 49.78% 
Claims included 1429489 50.22% 
Total claims in source data 2846606 100.00% 
4.1.2 Readmission	  Rates	  Compared	  to	  Published	  Rates	  
CMS publishes Risk-Standardized Readmission Rates (RSRRs) using a process 
which compares an estimated readmission rate per hospital to observed rates per hospital 
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per year, (Table 7).  The “Medicare Hospital Quality Chartbook 2012: Performance 
Report on Outcome Measures” [51] shows median value by condition per year.    
Table 7.  Medicare Hospital Quality Chartbook 2012 readmission rates. 
 
This study used a 5% LDS sample, and there was insufficient data available to 
determine a median value of hospital-based readmission rates when aggregating at the 
principal diagnosis code.  AMI in this study has fewer claims records per year than the 
number of hospitals, resulting in median values of 100%, 50%, 33%, and down to 0%.  
Therefore, this study used sample proportions across all states and hospitals (Table 8).  
Consequently, there are two measures of central tendency: sample proportion from this 
study and CMS’s median readmission.  AMI proportion values appear to be lower than 
the median numbers, while HF and PN appear to be the same.   
Table 8.  Readmission proportions with 95% confidence intervals. 
Conditions 2008 2009 2010 2011 
AMI 16.1 (14.6, 17.7) n=2158  
16.8 (15.2, 18.5) 
n=2032 
16.5 (14.9, 18.2) 
n=1911  
16.7 (15.0, 18.4) 
n=1927 
HF 24.8 (24.2, 25.4) n=19,457  
24.9 (24.3, 25.5) 
n=20,605  
24.4 (23.8, 25.0) 
n=18,278  
24.6 (23.9, 25.2) 
n=19,305 
PN 17.8 (17.2, 18.4) n=15,502  
18.2 (17.6, 18.9) 
n=15,080  
18.1 (17.5, 18.8) 
n=13,648  
18.1 (17.5, 18.7) 
n=15,360 
 
Both sets of numbers fall within a range of published literature for the three 
conditions of interest.  Repeatability is complicated by a number of factors.  Predating the 
national standard, readmission was calculated by a single hospital and extrapolated 
upwards, or by aggregated state data and then extrapolated upward.  The NQF and 
AHRQ publish guideline measures and associated rates, but those may contain Veterans 
Affairs (VA) data or data for persons <65 years of age.   
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Given the overall published range and wide delta from study to study, the numbers 
calculated and listed above by this study are reasonable. 
4.2 Descriptive	  Statistics	  for	  POA	  Indicators	  
There were few studies within the published literature that contain raw statistics 
detailing POA data itself.  In this section, brief characterizations of different POA aspects 
are made to provide a better understanding of the data used within the regressions. 
4.2.1 Raw	  POA	  Numbers	  
In FY2008, a large number of providers regularly included POA flags for all of their 
administrative claims, not just claims containing a HAC condition.  Other providers only 
supplied POA data when a HAC existed in the secondary diagnosis fields.  By 2010 with 
additional guidance from CMS, all providers regularly use POA indicators for all 
secondary diagnosis codes.  Overall, within the study time period 2007Q4 through 
2011Q4, 67% or approximately 1.9M claims contain valid POA flags.   
The raw administrative claims data contains ten POA fields defined as one character 
in length.  CMS defined six possible values to be used within the POA fields (Table 5).  
The raw data contains additional characters.  They are to contain the values listed in 
Table 5.  However, after adjusting for uppercase/lowercase settings, these fields contain a 
wide assortment beyond the expected CMS defined values seen in Table 9 below.   
Table 9.  POA indicator frequencies. 
POA Indicator Value Count Percent 
Defined by CMS 
Y  13,946,037  80.62% 
W  4,644  0.03% 
N  967,712  5.59% 
U  221,491  1.28% 
1  1,518,508  8.78% 
Undefined 0,2,3,4,5,6,7,8,9,D,E,I,P,S,V,X,'  640,651  3.70% 
 
It should be noted here that POA=no does not necessarily imply wrongdoing by the 
provider.  Many of these conditions indicated as POA=no are complications of other 
conditions.  Unknown drug allergy, for example, may cause additional complications and 
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therefore will be recorded as POA=no because the allergy happened within the hospital.  
The ‘U’ flag represents a condition for which there isn’t enough clinical documentation 
to determine if the patient had the condition at admission.  As noted in Section 2.3.3.2, 
for the purposes of categorizing “hospital acquired” status, if the medical record is 
insufficient to show POA=no, it is also insufficient to show conclusively POA=yes, and 
therefore researchers should consider these cases equivalent to POA=no. 
The undefined POA flags represent approximately 3.8% of all the valid flags found 
within the research database.  After verifying these characters were indeed in the raw 
LDS files, I contacted ResDAC concerning the unexpected POA flag values.  Their 
response stated provider codes “are not cleaned and can have errors. This information 
would indicate … very high background error rate.”[52] In addition to extra characters, 
there may be missing POA flags, as noted in a CMS working document “intended to 
communicate format and changes … found within the 2008 LDS Standard Analytical 
Files (SAFs).”[53] 
 
The POA fields are included in the 2008 inpatient LDS SAF. However, there may be 
some null POA values due to an error which occurred in the CMS Common Working 
File. Claims processed during July through October 2008 did not include POA, therefore, 
any adjustments processed during this time for claims with 2008 service dates were 
affected. This primarily impacts claims with service dates of October through December 
2008. 
 
So, I encoded any POA not approved by CMS as “null” for statistical processing. 
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4.2.2 Raw	  POA	  by	  Diagnostic	  Column	  Position	  
Charting POA indicator versus which administrative diagnostic column the POA 
indicator is associated with (Figure 10), shows a number of interesting things.  Note 
column 1 (principal diagnosis) is overwhelmingly POA=yes; most POA=no secondary 
diagnosis are found in column 2 and taper off; POA=no represent a relatively small 
proportion of claims; the number of columns available for reporting secondary diagnoses 
codes expanded from 10-25 in 2011 as noted by the drop-off to zero.  
 
Figure 10.  POA indicators per administrative claims diagnosis column. 
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Frequencies are remarkably consistent year-to-year as seen by raw counts, not 
adjusted values, from a 5% LDS Inpatient file.  Not all fields are used to represent a 
patient’s diagnosis as noted by the gradual trailing off of “Y” values with a curious step-
down from column 1 to column 2 caused by the principal diagnosis code being not 
hospital acquired.  The odd right-hand tail in column 10 is caused by some providers who 
were able to submit ten diagnostic values compared to the majority who submitted only 
nine secondary diagnosis columns.  The most frequent place to find an “N” is in column 
2.  There was speculation raised in the HAC/POA committee minutes after the 
HAC/POA program inception and before the 2008Q4 effective date, suggesting hospitals 
would try to game the system by “burying” their POA=no conditions farther down in the 
secondary diagnosis list in an effort to reduce the appearance of HACs at their institution.  
This doesn’t appear to be the practice, as column 2 contains three times the number of 
“N” values as column 9.  The number of secondary diagnosis fields expanded to 25 in 
2011, which did not effect the trajectory of use.  (As a reminder, this study used only 
columns 1 through 10 to be compatible with previous years not having as many fields.)  
This pattern persisted through providers, states, and CMS regions.  POA=no flags are 
found mostly in the second position decreasing thereafter and almost zero for first 
diagnosis position.   
 
4.2.3 POA	  Rates	  for	  Investigated	  Conditions	  
How do POA=no rates compare to frequencies of the ICD-9 codes under which they 
fall?  Appendix D – POA Frequency Data contains a full listing of ICD-9 primary 
diagnosis codes and the associated POA frequency within that diagnosis.  If POA data 
represents in-hospital complications for patients, one would expect these distributions to 
be comparable across the different ICD-9 codes.  In addition, it would also appear to be 
reasonable to assume POA rates are comparable across different facets of data.  To test 
this, I created bullet charts to visually compare this idea.  The bullet charts used 
beneficiary gender and age as facets.  Each bullet has a larger bar representing the 
frequency of the corresponding ICD-9 primary diagnosis code and a smaller bar 
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representing the proportions of any POA=no on the administrative claim.  The line on the 
small bar is its standard error.  Each small chart is a facet of the contrasting variable 
(Figure 11). 
 
Figure 11.  Proportion bullet chart for gender. 
When faceting by gender, the general assumption appears true: having any POA=no 
on an administrative claim is proportional to the frequency of the primary diagnosis code.  
Using HF 42830 as an example, female patients represent about 65% of the total patients, 
and of those female patients, their “any POA=no on administrative claim?” rate is about 
66% with a standard error of about ±1.5%, meaning the two rates are roughly equivalent.  
There are three exceptions highlighted in Figure 11 for conditions: PN 486 (female) and 
AMI 41091 (male and female).  In the first case, the numbers are significant, but only 
just.  For the second condition, the rates really appear to be different.   
I repeated this process, faceting the data by beneficiary age (Figure 12).  Across all of 
the age facets, having any POA=no on an administrative claim is proportional to the 
frequency of the primary diagnosis code with the exception of those conditions 
highlighted: PN48242 (80 to 84), HF 42833 (>84), HF 42830 (80 to 84), and HF 42843 
(>84).  In these cases, the rates are at the point of significance, not really exceeding it.   
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Figure 12.  Proportion bullet chart for age. 
I investigated the highlighted codes further.  The distributions do not show any other 
relationship between ICD-9 code, age or gender, and POA.  Whatever statistical 
differences exist may not be clinical in nature. 
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4.2.4 CMS	  Regions	  
Hospital CMS regions were not statistically significant in any of the HF nor PN data 
sets (Figure 13).  Within AMI, the Seattle region was statistically significant compared to 
its peers.   
 
Figure 13.  POA percent and claim counts of 30-day readmissions by CMS regional centers. 
 
This chart shows the Seattle area’s smaller POA=no percent for 30-day readmissions.  
Examining actual claim counts, however, reveals a probable data anomaly caused by 
insufficient data.  There is no information in the literature suggesting AMI patients have 
fewer in-hospital secondary conditions compared to any other region.  Therefore, I 
removed CMS regions as a predictor. 
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4.2.5 Q-­‐Q	  Plots	  for	  Hospital-­‐level	  POA	  Rates	  
Hospital-level all-condition POA rates are shown below (Figure 14).  The blue line 
represents the Quantile-Quantile line.  Hospitals with no claims in a given year have been 
removed.   
 
Figure 14.  Q-Q plots of hospital-level POA reporting rates. 
The years 2008 and 2009 were early years for the HAC/POA program.  This ramp-up 
period can bee seen in 2008.  In 2009, the situation became more stable.  In 2010 and 
2011 only slight changes can be seen between HF and PN.  POA reporting by providers 
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was spotty in both coverage and content with some providers not supplying indicators, as 
seen by the long left-hand tails in 2008.  Other hospitals supplied POA data all the time, 
as a matter of policy, as seen by the rising right-hand tails.  Examining claims from the 
early years by these providers yields POA values of ‘1’ (exempt from reporting), in all 
fields, but these represent a small percent of total claims.  The ‘1’ flag as a POA indicator 
was phased out mid-2010 and is no longer a source for confounding.  Still other hospitals 
only supply POA data when a HAC condition was present on the administrative claim 
resulting in an overall low rate for those providers.  CMS clarified its POA reporting 
policy for FY2010 and overall rates climbed.  Each chart is slightly different for each 
condition.  In all charts, a vast majority of points coincide with the Q-Q line.   
4.3 POA	  Regression	  Results	  
This section presents the result of logistic regression modeling of hospital 
readmission. 
4.3.1 Evaluation	  of	  POA	  Predictors	  Overall	  
As defined in Section 3.4.2, p1 “binary variable (p_no_flag) indicating claim has a 
POA=no condition.”  This predictor was statistically significant within all of the AMI 
datasets and the 15-day HF dataset, while not statistically significant for the 7-day and 
30-day HF and all PN datasets.  In each condition and in each readmission period 
investigated, the odds ratios are greater than 1.0, indicating an increase in readmission, 
(Figure 15).  Green lines are statistically significant and red lines are not.   
AMI patients can be treated in a number of ways, some with procedures (81%) and 
some without (19%).  As a follow-up exercise, Chi-Square tests were generated 
comparing AMI variables for procedure status, POA status, and 30-day readmission 
status.  As seen in Table 10 below, the variable procedure status and readmission status 
are independent.  However, the variables procedure status and POA status are not 
independent.  Likewise, the variables POA status and 30-day readmission status are also 
not independent.  There is some systematic connection between POA status and 
  
 68 
procedure status indicating a more complicated patient stay leading to a greater likelihood 
of hospital readmission. 
Table 10.  Chi-Square test of independence between POA, ICD-9-CM procedures, and readmission. 
AMI claims Pearson's Chi-squared test, df=1 P-value 
Procedure status 
30-day readmission 0.1299469 0.7184871 
Procedure status 
POA events 295.1906 < 0.000001 
POA events  
30-day readmission 40.3326 < 0.000001 
Procedure status and POA events 
30-day readmission 41.58003 < 0.000001 
 
From this table, I make the following observations: First, AMIs requiring surgical 
intervention carries a greater chance of complications, which result in both increased 
POA=no reporting and increased readmissions.  Second, HF and PN are medical 
conditions usually accompanied by comorbidities.  The patient is treated for the most 
serious condition first and then once stabilized, will be treated for other conditions.  The 
timeframe between admission and subsequent treatment could account for the muddling 
of POA indicators because the subsequent treatment did not happen on the first day of the 
claim.   
The AMI odds ratios have a wider confidence interval due to the smaller sample 
sizes.  30-day readmission appears to have a greater correlation to readmission than 7-day 
or 15-day. 
 
 
Figure 15.  Odds ratio of POA flag for 7-day, 15-day, and 30-day readmission periods. 
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In Section 3.4.2, p2 is defined as “numeric variable (p_no_count) indicating the 
number from (0 through 10) of POA=no conditions on a claim record.”  This predictor 
was approaching statistical significant for each dataset.  However, with odds ratios so 
close to 1.0, it is unlikely these results are anything but noise not reflecting clinical 
patterns.  This variable needs more data to be an effective predictor.  It may also be the 
case that the regression conflates the POA count with utilization days to produce patterns 
where none exist.  For these reasons, I deemed this variable an unreliable indicator and 
removed it from the final consideration.  I conducted no further analysis on p2. 
 
Figure 16.  Odds ratio of POA=no count for 7-day, 15-day, and 30-day readmission periods. 
 
In Section 3.4.2, p3 is defined as “hospital POA adoption or usage rate.”  All of the 
AMI readmission periods across all 4 years were statistically insignificant (Figure 17).  
Green lines are statistically significant and red lines are not.  PN 30-day readmission for 
2009 and 2010 were also statistically insignificant, but the remainder were all significant.  
For AMI, the odds ratios themselves varied above and below 1.0 based on readmission 
period (all the 7-day odds ratios were > 1.0, while all of the 30-day odds ratios were < 
1.0).   
For the statistically significant odds ratios, all of the 2008 confidence intervals are 
wider than other years due to lack of data as the HAC/POA program got under way.  The 
2008 odd ratios are all askew from their peers as well. 
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Figure 17.  Odds ratios for hospital POA rate for 7-day, 15-day, and 30-day readmission periods. 
 
4.3.2 ROC	  Analysis	  
To assist in model comparison, I created area under receiver operating characteristic 
ROC curves across each condition for the base model and base model plus POA data, and 
compared to 30-day readmission measures identified by Yale-CORE readmission 
measures created under contract for CMS.[49,50, 2]  See Table 11.  This study’s rates are 
  
 71 
lower than the published rates, but are above the age and gender models referenced.  The 
addition of POA data improves upon each model slightly. 
Table 11.  Comparison of area under ROC curves. 
Condition Base Model Base Model plus POA CMS Methodology 
AMI 0.6149 0.6157 0.63 
HF 0.5558 0.5578 0.60 
PN 0.5894 0.5896 0.63 
 
4.3.3 Evaluation	  for	  AMI	  
Hypothesis H1 indicates a connection between AMI administrative claims having 
POA=no and patient readmission.  Comparing selected odds ratios for 30-day 
readmission shows the effect of the POA=no flag is greater than the effect for either 
gender or length of stay, but less than age 80 to 84 or age > 84 (Figure 18).   
 
Figure 18.  Odds ratios for AMI 30-day readmission for base model with POA. 
I ran a backward Generalized Linear Models (GLM) variable elimination process on 
the AMI 30-day readmission model.  These results are presented in Figure 19 below.  The 
overall odds ratios became smaller, but the relative significance stayed the same. 
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Figure 19.  Odds ratios for AMI 30-day readmission after GLM backward elimination procedure. 
 
To further understand the effect, I plotted AMI POA=no trends per quarter from 
2009Q1 through 2011Q4.  Several AMI ICD codes did not have enough data to make 
reasonable trends across the time period.  So I discarded them from further analysis.  
Charting was limited to the 3 most prevalent codes: 41011, 41041, and 41091.  See 
Figure 20 below.   
 
Figure 20.  POA=no proportions of AMI diagnosis per quarter. 
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Codes 41011 and 41041 have stable or slightly declining rates respectively.  41091 
has an increasing trend over time.  This data does not appear to have any time-dependent 
trend.  I generated a second set of trends containing POA=no, POA=yes, and total claims 
for ICD code 41091 (Figure 21).  The overall incident rate falls over time (blue line), yet 
the POA=no rate remains steady over time (red line) resulting in an overall rising trend 
seen in the previous chart.  I generated similar charts for 41011 and 41041, and they 
appear similarly: overall rates decrease slightly and the POA=no rate is constant quarter 
over quarter, resulting in a steady trend (41011) and a slightly decreasing trend (41041) 
over time.  The difference between 41091 and the others is the magnitude of POA=no:  it 
is 1.5 through 2.5 times the others with a wider variance.  These rates appear to be in line 
with the American Journal of Cardiology report “Recent Trends in Hospitalization for 
Acute Myocardial Infarction” [54], in which the authors cite decreased mortality for AMI 
with increased complications.  It is, perhaps, these complications detected through the 
POA=no data. 
 
 
Figure 21.  Population-adjusted POA values by quarter for principal diagnostic code 41091. 
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4.3.4 Evaluation	  for	  HF	  
I plotted HF POA=no trends per quarter from 2009Q1 through 2011Q4 (Figure 22).  
Several HF ICD codes did not have enough data to make reasonable trends and were 
discarded from further analysis.  I grouped other HF ICD codes using the first 4 ICD-9 
digits as follows: 
4282x = {42820 42821 42822 42823} 
4283x = {42830 42831 42833} 
HF POA=no rates are with few exceptions smaller than AMI rates.  
 
 
Figure 22.  POA=no proportions of HF diagnosis per quarter. 
I created and compared independent plots for each individual ICD-9 code group. All 
of these charts indicate a small POA=no proportion.  I chose ICD-9 40491 as 
representative and charted to visualize the POA=yes/POA=no proportions (Figure 23).  
Notice how low the POA=no values per quarter are compared to the total.  With such a 
consistently small set of data with which to work, it is surprising to see the “any POA=no 
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on administrative claim” predictor variable on the edge of statistical significance, in this 
case indicating increased readmission odds.   
 
Figure 23.  Population-adjusted POA values by quarter for principal diagnostic code 40491. 
Another measurement from which to assess POA data is CMS’s excess readmission 
rations as calculated for the 2013 hospital readmission reduction program.  Comparisons 
between HF excess readmissions (CMS data) and POA rate (this study) are both per-
hospital measures (Figure 24).  Excess readmissions ratios less than 1.0 indicate hospitals 
achieving better than expected readmission results.  Excess hospital readmissions are 
calculated to have similar distributions regardless of hospital size.  Note hospitals with 
rates lower than 1.0 have higher POA usage rates.  As hospital size gets larger, POA rate 
increases.  This can be seen in the distribution ribbon at the x-axis of each chart.  The 
POA utilization rate distributions do vary with hospital size as seen by the distribution 
ribbon along the y-axis of each chart.  Hospitals in the first quartile size have a lower 
POA utilization rate.  Those in the forth quartile hospital size have high POA utilization 
rates.  The slope direction across all quartiles is negative indicating some correlation 
between lower expected readmission rates and higher POA utilization, and between 
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higher readmission and lower POA utilization.  Once can see a consistent change from 
quartile to quartile of an increasing POA rate, however the difference between groups is 
not significant. 
 
Figure 24.  Scatter plot of excess HF readmission compared to hospital's POA usage.  
 
4.3.5 Evaluation	  for	  PN	  
I plotted PN POA=no trends per quarter from 2009Q1 through 2011Q4 (Figure 25).  
Several PN ICD codes did not have enough data to make reasonable trends and were 
discarded from further analysis.  PN POA=no rates lay between HF rates and AMI rates.  
I created and compared independent plots for each individual ICD-9 code group. 
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Figure 25.  POA=no proportions of PN diagnosis per quarter. 
Trends for the single largest principal diagnostic ICD code 486 (Figure 26) show a 
larger POA=no count overall compared to HF and not quite as much as for AMI.  There 
appears to be some seasonality as seen by the total and POA=yes points: consistent peaks 
of Q1 and valleys of Q3.  The POA=no points indicate a remarkably consistent quarter-
to-quarter rate. 
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Figure 26.   Population-adjusted POA values by quarter for principal diagnostic code 486. 
 
4.4 Model	  Summary	  
There is a difference between predictors for AMI and for HF and PN.  These appear 
to be related to either the patient (disease progression, comorbidities, etc.) or specific 
procedure as demonstrated by the non-overlapping predictors and significance results.  It 
is possible that changing from a 5% sample to a 20% sample would increase the 
confidence surrounding the odds ratios without moving the estimation.  It is also possible 
more data could reduce the effect to noise and insignificance.   
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5 Conclusion	  
The purpose of this study is to understand and assess the usefulness of POA 
indicators as a predictor of hospital readmission. 
5.1 Findings	  
“Would POA indicators be a useful set of data to include when modeling hospital 
readmissions?”  To test this question, based on the literature search results of Section 2.4, 
three hypotheses were proposed in Section 3.4.2, and detailed results presented in Section 
4.3.  For convenience, the hypotheses and POA variables are restarted here. 
 
H1 The presence of POA=no indicators on an administrative claim is a 
predictor of hospital readmission. 
p1 is defined as a dichotomous variable set to 1 if any POA=no indicators 
were found on the administrative claim.   
 
H2 The number of POA=no indicators on an administrative claim is a 
predictor of hospital readmission. 
p2 is defined as the count of the number of POA=no indicators found on 
the given administrative claim.   
 
H3 The rate at which a hospital fills POA fields across all of its 
administrative claims is a predictor of hospital readmission. 
p3 was set as an aggregated variable at the hospital level by counting all 
claims with any POA indicator set on any of its administrative claims.  
Due to the fluctuation in POA adoption, CMS directions or guidance, and 
overall adherence within the early years of the HAC/POA program, I 
divided this variable into rates per hospital per claim year.   
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An idea from the literature search that POA data can cluster around certain diseases, 
codes, or procedures led to the possibility of linking diseases groups together.  This led to 
the development of hypotheses H1 and H2 paired with variables: 
p1:  Were there any POA=no conditions on the given administrative claim? 
p2:  How many POA=no conditions exist on the given administrative claim? 
H1 proved to be statistically significant for AMI at all readmission periods, and for 
HF at the 15-day readmission period.  All had an odds ratio value associated with an 
increase in likelihood of hospital readmission.  H2 was not statistically significant for any 
disease nor any readmission period.  I speculate that using a 5% sample did not leave 
enough claims in the resulting pool. 
Another idea from the literature search, the idea that a provider’s POA rates may vary 
from its peers, led to creation of a hospital-based POA metric that could be tracked over 
time.  Hypothesis H3 led to development of variable p3 defined as any POA=no occurring 
on any administrative claim for a given hospital.  Rates were statistically significant for 
HF and PN, reflecting a reduced likelihood of a readmission event.  I speculate, based 
upon the literature, that the reduced likelihood reflects documentation practices of the 
hospital (staff training, technology, ensuring the correct staff document POA 
assessments, etc.). 
As a conclusion, I restate an observation made in Section 2.4:  There is a nuance to 
POA data.  Defining POA metrics and applying them over a wide array of conditions 
may not produce consistent results.   
5.2 Future	  Directions	  
A logical follow-on to this study is to predict hospital readmissions using POA data.  
A new set of predictive algorithms have been developed recently, adapted and evolved 
from a number of sources.  These are generally non-parametric techniques built on the 
computational power of repeated calculations called ensembles.  For example, one older 
technique builds a decision tree by repeatedly partitioning the input dataset into smaller 
portions until a clear yes/no prediction can be made for any input to the tree.  This 
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technique learns datasets very well, and can over-fit the data resulting in poor 
performance when applied to new data.  The power of the newer predictive algorithms 
lies in their ability to create thousands of these decision trees (a forest of decision trees) 
in a relatively short period of time.  With computational power comes yet another 
approach: combine a small random change into each decision tree; a change such as 
omitting a predictor variable, (a random forest of decision trees).  The random aspect 
works by choosing to not use one of the predictor variables during the construction of the 
internal decision points.  The final prediction is the sum of all predictions over all of the 
decision trees in the forest (the ensemble).  These random permutations of the datasets 
into ensembles outperform traditional statistical techniques.   
Shams, Ajorlou, and Yang built a predictive model using several of the newer 
techniques to help the VA understand which patients were likely to be readmitted before 
30 days.[55]  The following diagram (Figure 27) summarizes their findings.  PHSF is a 
variant of random forest.  There are newer neural network algorithms that use the random 
permutation and ensemble ideas that are on-par with random forests.  
 
Figure 27.  Comparison of newer predictive techniques compared to logistic regression.   
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Most of these new ensemble techniques have no limit to the width of the input 
dataset, meaning POA data could be added without penalty and with benefit.  Adding raw 
POA data may have some benefit.  More than likely, development of new POA variables 
would have a much better effect.  I would also like to pursue the study of using graph 
theory to connect POA data to primary diagnosis, secondary diagnoses, procedures, and 
to DRGs or their attributes.  Rather than hunt and peck for possible relationships, find 
them automatically via machine learning.   
All of the information presented is inpatient data.  None of the patient’s other health 
care is represented here.  Another avenue to follow up is combining POA data with 
outpatient records, Part D drug benefit information, etc., building up an entire patient-
centric view of disease and its management for the purposes of tracking care and 
outcomes. 
5.3 Summary	  
Within this study, I have assembled a data mining research database the purpose of 
which was to learn about POA data in general and POA data in conjunction with hospital 
readmission modeling in particular.  I believe the approach used within this study 
captures the essence of Biomedical Health Informatics because it demonstrates precisely 
a technical sophistication defined by pulling health data from disparate sources and 
integrating them into a working whole, in combination with statistical approaches to 
needed pose hypotheses and evaluate them using statistical models.  In addition, this 
effort required an acquired in-depth understanding of U.S. health care administrative 
claims data.  The study shows an ability to draw inferences and test them in an area 
where little work has been done to date using contemporary statistical methods. 
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Appendix	  A	  –	  Glossary	  
Understanding anything in the U.S. health care system requires an understanding of 
the alphabet soup of agencies, laws, programs, committees, advisory panels, etc., driving 
health care change.  This table is a short list created to clarify HAC/POA and 30 day 
readmission.  The following table is a glossary of terms used in this thesis. 
 
Acronym / Organization Definition 
ACA / PPACA Patient Protection and Affordable Care Act 
Public Law 111-148, 2010. 
AHRQ 
 
Agency for Healthcare Research and Quality 
1998, Part of HHS.  http://www.AHRQ.Gov 
Misson: “produce evidence to make health care safer, higher quality, more accessible, 
equitable, and affordable, and to work with the U.S. Department of Health and Human 
Services (HHS) and other partners to make sure that the evidence is understood and 
used.” 
CMS Center for Medicare and Medicaid Services 
Established: 1965 
HCAHPS Hospital Consumer Assessment of Healthcare Provider Systems 
Established: 2002.  Purpose: CMS partners with AHRQ to develop national patient 
survey.  2005, NQF endorsed methods and approach, CMS implemented survey in 2006. 
HCUP Healthcare Cost and Utilization Project 
1988, under AHRQ 
Purpose:  tracks treatments and outcomes 
HHS Department of Health and Human Services 
Part of the U.S. Federal government which contains CMS 
IPAB Independent Payment Advisory Board 
2010, Agency created under ACA.  Charged with identifying and implementing savings 
in Medicare without effecting coverage or quality. 
IQR Hospital Inpatient Quality Reporting System 
Section 501(b) Medicare Prescription Drug Improvement and Modernization Act of 2003 
0.4% reduction of payments to hospitals that do not report quality measures.  Increased to 
2.0% in Deficit Reduction Act of 2005.  A portion of quality data collected is posted on 
http://www.HospitalCompare.HHS.Gov website.   
Joint Commission An independent, not-for-profit organization that accredits and certifies health care 
organizations in the United States   
MedPAC Medicare Payment Advisory Committee 
Established: 2007.  Purpose: Advise Congress about Medicare payments, quality of care 
delivered, and access to care. 
MMA Medicare Prescription Drug, Improvement and Modernization Act 
Authorized Medicare Part D coverage for prescription drugs, health savings accounts, 
and national reporting program 
NIH National Institutes of Health 
Established: 1931.  Purpose: Preventing and curing disease 
NQF National Quality Forum 
Mission: “1) Building consensus on national priorities, 2) Endorsing national consensus 
standards, and 3) Promoting goals through education and outreach programs. 
QuIC Quality Interagency Coordinating Committee 
Mission: To ensure that all Federal agencies involved in purchasing, providing, studying, 
or regulating health care services are working in a coordinated way toward the common 
goal of improving quality of care. 
VA Veterans Affairs 
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Acronym Definition 
ACA Patient Protection and Affordable Care Act of 2010 
ADE Adverse Drug Events 
AMI Acute Myocardial Infarction 
CABG Coronary Arterial Bypass Graft 
CAS Carotid Angioplasty and Stenting 
CAUTI Catheter-Associated Urinary Tract Infection 
CC Complications or Comorbidities 
CEA Carotid Endarterectomy 
CDS Clinical Decision Support 
DRA Deficit Reduction Act 
DRG Diagnostic Related Group 
EMR Electronic Medical Record 
FIPS Federal Information Processing Standard 
GLM Generalized Linear Models 
HAC Hospital Acquired Condition 
HF Heart Failure 
HIMSS Health Information Management Systems Society 
HIT/IT Health Information Technology / Information Technology 
ICD-9-CM International Classification of Disease, 9th Revision, with Clinical Modification 
IPPS Inpatient Prospective Payment System 
LDS Limited Data Set 
LOS length of stay 
MCC Major Complications or Comorbidities 
MILI University of Minnesota Carlson School, Medical Industry Leadership Institute 
MMA Medicare Prescription Drug, Improvement and Modernization Act 
MS-DRG Medicare Severity Diagnostic Related Group 
PIC Potential Inpatient Conditions 
POA Present on Admission 
PN Pneumonia 
ResDAC Research Data Assistance Center 
RSRR Risk-Standardized Readmission Rates 
SAF Standard Analytical Files 
SNF Skilled Nursing Facility 
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Appendix	  B	  –	  Principal	  Diagnostic	  Codes	  for	  AMI,	  HF,	  and	  PN	  
CMS currently assesses hospital readmission penalties for acute myocardial infarction 
AMI, HF, PN.  This study limits conditions to this set as defined by the administrative 
claim principal diagnosis field using the following table. 
 
Condition 
ICD-9-CM  
Diagnosis Code Description 
AMI 41000 Acute myocardial infarction of anterolateral wall, episode of care unspecified 
AMI 41001 Acute myocardial infarction of anterolateral wall, initial episode of care 
AMI 41010 Acute myocardial infarction of other anterior wall, episode of care unspecified 
AMI 41011 Acute myocardial infarction of other anterior wall, initial episode of care 
AMI 41020 Acute myocardial infarction of inferolateral wall, episode of care unspecified 
AMI 41021 Acute myocardial infarction of inferolateral wall, initial episode of care 
AMI 41030 Acute myocardial infarction of inferoposterior wall, episode of care unspecified 
AMI 41031 Acute myocardial infarction of inferoposterior wall, initial episode of care 
AMI 41040 Acute myocardial infarction of other inferior wall, episode of care unspecified 
AMI 41041 Acute myocardial infarction of other inferior wall, initial episode of care 
AMI 41050 Acute myocardial infarction of other lateral wall, episode of care unspecified 
AMI 41051 Acute myocardial infarction of other lateral wall, initial episode of care 
AMI 41080 Acute myocardial infarction of other specified sites, episode of care unspecified 
AMI 41081 Acute myocardial infarction of other specified sites, initial episode of care 
AMI 41090 Acute myocardial infarction of unspecified site, episode of care unspecified 
AMI 41091 Acute myocardial infarction of unspecified site, initial episode of care 
HF 40201 Malignant hypertensive heart disease with heart failure  
HF 40211 Benign hypertensive heart disease with heart failure. Unspecified hypertensive 
heart disease with heart failure  
HF 40291 Hypertensive heart and chronic kidney disease, malignant, with heart failure 
and with chronic kidney disease stage I through stage IV, or unspecified  
HF 40401 Hypertensive heart and chronic kidney disease, malignant, with heart failure 
and with chronic kidney disease stage V or end-stage renal disease  
HF 40403 Hypertensive heart and chronic kidney disease, benign, with heart failure and 
with chronic kidney disease stage I through stage IV, or unspecified  
HF 40411 Hypertensive heart and chronic kidney disease, benign, with heart failure and 
chronic kidney disease stage V or end-stage renal disease  
HF 40413 Hypertensive heart and chronic kidney disease, unspecified, with heart failure 
and with chronic kidney disease stage I through stage IV, or unspecified  
HF 40491 Hypertensive heart and chronic kidney disease, unspecified, with heart failure 
and chronic kidney disease stage V or end stage renal disease  
HF 40493 Congestive heart failure, unspecified.  Left heart failure  
HF 4280 Systolic heart failure, unspecified. Acute systolic heart failure  
HF 4281 Chronic systolic heart failure. Acute on chronic systolic heart failure  
HF 42820 Diastolic heart failure, unspecified  
HF 42821 Acute diastolic heart failure  
HF 42822 Chronic diastolic heart failure  
HF 42823 Acute or chronic diastolic heart failure 
HF 42830 Combined systolic and diastolic heart failure, unspecified  
HF 42831 Acute combined systolic and diastolic heart failure  
HF 42832 Chronic combined systolic and diastolic heart failure  
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Condition 
ICD-9-CM  
Diagnosis Code Description 
HF 42833 Acute on chronic combined systolic and diastolic heart failure  
HF 42840 Heart failure, unspecified  
HF 42841 Malignant hypertensive heart disease with heart failure  
HF 42842 Benign hypertensive heart disease with heart failure. Unspecified hypertensive 
heart disease with heart failure  
HF 42843 Hypertensive heart and chronic kidney disease, malignant, with heart failure 
and with chronic kidney disease stage I through stage IV, or unspecified  
HF 4289 Hypertensive heart and chronic kidney disease, malignant, with heart failure 
and with chronic kidney disease stage V or end-stage renal disease  
PN 4800 Pneumonia due to adenovirus 
PN 4801 Pneumonia due to respiratory syncytial virus 
PN 4802 Pneumonia due to parainfluenza virus 
PN 4803 Pneumonia due to SARS-associated coronavirus 
PN 4808 Pneumonia due to other virus not elsewhere classified 
PN 4809 Viral pneumonia, unspecified 
PN 481 Pneumococcal pneumonia [Streptococcus pneumoniae pneumonia] 
PN 4820 Pneumonia due to Klebsiella pneumoniae 
PN 4821 Pneumonia due to Pseudomonas 
PN 4822 Pneumonia due to Hemophilus influenzae [H. influenzae] 
PN 48230 Pneumonia due to Streptococcus, unspecified 
PN 48231 Pneumonia due to Streptococcus, group A 
PN 48232 Pneumonia due to Streptococcus, group B 
PN 48239 Pneumonia due to other Streptococcus 
PN 48240 Pneumonia due to Staphylococcus, unspecified 
PN 48241 Methicillin-susceptible pneumonia due to Staphylococcus aureus 
PN 48242 Methicillin-resistant pneumonia due to Staphylococcus aureus 
PN 48249 Other Staphylococcus pneumonia 
PN 48281 Pneumonia due to anaerobes 
PN 48282 Pneumonia due to escherichia coli [E. coli] 
PN 48283 Pneumonia due to other gram-negative bacteria 
PN 48284 Pneumonia due to Legionnaires' disease 
PN 48289 Pneumonia due to other specified bacteria 
PN 4829 Bacterial pneumonia, unspecified 
PN 4830 Pneumonia due to mycoplasma pneumoniae 
PN 4831 Pneumonia due to chlamydia 
PN 4838 Pneumonia due to other specified organism 
PN 4841 Pneumonia in cytomegalic inclusion disease 
PN 4843 Pneumonia in whooping cough 
PN 4845 Pneumonia in anthrax 
PN 4846 Pneumonia in aspergillosis 
PN 4847 Pneumonia in other systemic mycoses 
PN 4848 Pneumonia in other infectious diseases classified elsewhere 
PN 485 Bronchopneumonia, organism unspecified 
PN 486 Pneumonia, organism unspecified 
PN 4870 Influenza with pneumonia 
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Appendix	  C	  –	  Detailed	  Regression	  Output	  
The following pages contain all of the regression output from model 3.1, shortened to 
save space.  Each regression contains all of the variables described in Section 3.4.2.  In 
particular, the following text remains unchanged for each regression.  POA variables are 
highlighted. 
 
Call: 
glm(formula = yyy ~ p_no_flag + I(t_2008 * h_2008_poa_rate) +  
    I(t_2009 * h_2009_poa_rate) + I(t_2010 * h_2010_poa_rate) +  
    I(t_2011 * h_2011_poa_rate) + b_gndr + b_dob + c_util_day +  
    c_cost + c_cost_outlier + d_type + d_mdc + h_beds + h_urban,  
    family = binomial(logit), data = df) 
 
Significance codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
 
Dispersion parameter for binomial family taken to be 1 
 
 
The dataset ‘df’ was replaced with one of the following: 
 AMI Acute myocardial infarction dataset 
 HF Heart Failure dataset 
 PN Pneumonia dataset 
 
The dependent variable, ‘yyy’ was replaced with one of the following in each dataset: 
 y_7 7-day readmission event 
 y_15 15-day readmission event 
 y_30 30-day readmission event 
 
This results in 3x3 combination of logistic regressions, the output of which is listed 
below. 
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AMI 7-day hospital readmission 
 
Deviance Residuals:  
    Min       1Q   Median       3Q      Max   
-1.2189  -0.4673  -0.4116  -0.3554   2.5226   
 
Coefficients: 
                              Estimate Std. Error z value Pr(>|z|)     
(Intercept)                 -1.790e+00  7.384e-01  -2.424 0.015346 *   
p_no_flag1                   2.437e-01  9.857e-02   2.472 0.013439 *   
I(t_2008 * h_2008_poa_rate)  2.059e+00  1.483e+00   1.389 0.164906     
I(t_2009 * h_2009_poa_rate)  2.784e-01  4.906e-01   0.568 0.570364     
I(t_2010 * h_2010_poa_rate)  3.151e-01  4.330e-01   0.728 0.466753     
I(t_2011 * h_2011_poa_rate)  3.349e-01  5.922e-01   0.565 0.571765     
b_gndrF                      3.018e-01  8.633e-02   3.496 0.000472 *** 
b_dob70 Thru 74              1.664e-01  1.353e-01   1.230 0.218638     
b_dob75 Thru 79              2.812e-01  1.351e-01   2.082 0.037340 *   
b_dob80 Thru 84              2.678e-01  1.388e-01   1.930 0.053664 .   
b_dob>84                     2.538e-01  1.363e-01   1.862 0.062636 .   
c_util_day                   5.274e-02  1.131e-02   4.663 3.12e-06 *** 
c_cost                       6.278e-07  4.453e-06   0.141 0.887902     
c_cost_outlier              -2.432e-01  2.447e-01  -0.994 0.320296     
d_typeSURG                  -1.752e-01  1.029e-01  -1.703 0.088597 .   
d_mdc05                     -1.188e+00  7.051e-01  -1.684 0.092111 .   
d_mdcPRE                    -1.551e+01  2.466e+02  -0.063 0.949832     
h_beds                       1.068e-04  1.698e-04   0.629 0.529660     
h_urbanUrban                -7.114e-02  1.292e-01  -0.551 0.581951     
--- 
    Null deviance: 4411.4  on 7197  degrees of freedom 
Residual deviance: 4307.1  on 7179  degrees of freedom 
  (1559 observations deleted due to missingness) 
AIC: 4345.1 
 
Number of Fisher Scoring iterations: 14 
 
                                      OR        2.5 %       97.5 % 
(Intercept)                 1.669502e-01 3.338094e-02 6.636678e-01 
p_no_flag1                  1.275909e+00 1.050739e+00 1.546560e+00 
I(t_2008 * h_2008_poa_rate) 7.837393e+00 4.119999e-01 1.379607e+02 
I(t_2009 * h_2009_poa_rate) 1.321012e+00 5.016160e-01 3.433016e+00 
I(t_2010 * h_2010_poa_rate) 1.370402e+00 5.832431e-01 3.185098e+00 
I(t_2011 * h_2011_poa_rate) 1.397763e+00 4.329396e-01 4.415455e+00 
b_gndrF                     1.352347e+00 1.142170e+00 1.602329e+00 
b_dob70 Thru 74             1.181064e+00 9.057468e-01 1.540146e+00 
b_dob75 Thru 79             1.324744e+00 1.016543e+00 1.727069e+00 
b_dob80 Thru 84             1.307102e+00 9.955436e-01 1.716245e+00 
b_dob>84                    1.288952e+00 9.875531e-01 1.685906e+00 
c_util_day                  1.054155e+00 1.030810e+00 1.077595e+00 
c_cost                      1.000001e+00 9.999917e-01 1.000009e+00 
c_cost_outlier              7.841223e-01 4.756823e-01 1.244738e+00 
d_typeSURG                  8.393278e-01 6.864319e-01 1.027461e+00 
d_mdc05                     3.049581e-01 8.217347e-02 1.447582e+00 
d_mdcPRE                    1.830461e-07 4.654191e-80 9.882497e-79 
h_beds                      1.000107e+00 9.997655e-01 1.000432e+00 
h_urbanUrban                9.313355e-01 7.260521e-01 1.205468e+00 
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AMI 15-day hospital readmission 
 
Deviance Residuals:  
    Min       1Q   Median       3Q      Max   
-1.3790  -0.5464  -0.4829  -0.4198   2.8672   
 
Coefficients: 
                              Estimate Std. Error z value Pr(>|z|)     
(Intercept)                 -1.602e+00  6.749e-01  -2.373  0.01764 *   
p_no_flag1                   2.380e-01  8.385e-02   2.838  0.00453 **  
I(t_2008 * h_2008_poa_rate)  9.465e-02  1.322e+00   0.072  0.94292     
I(t_2009 * h_2009_poa_rate) -7.824e-03  4.242e-01  -0.018  0.98528     
I(t_2010 * h_2010_poa_rate)  1.237e-01  3.723e-01   0.332  0.73967     
I(t_2011 * h_2011_poa_rate)  2.975e-02  5.121e-01   0.058  0.95367     
b_gndrF                      2.146e-01  7.328e-02   2.929  0.00340 **  
b_dob70 Thru 74              1.268e-01  1.144e-01   1.108  0.26770     
b_dob75 Thru 79              2.136e-01  1.155e-01   1.849  0.06441 .   
b_dob80 Thru 84              3.363e-01  1.157e-01   2.906  0.00366 **  
b_dob>84                     2.695e-01  1.152e-01   2.339  0.01932 *   
c_util_day                   5.442e-02  9.787e-03   5.560  2.7e-08 *** 
c_cost                       1.126e-06  3.817e-06   0.295  0.76797     
c_cost_outlier              -3.217e-01  2.096e-01  -1.534  0.12494     
d_typeSURG                  -1.356e-01  8.813e-02  -1.539  0.12388     
d_mdc05                     -9.751e-01  6.479e-01  -1.505  0.13233     
d_mdcPRE                    -3.711e+00  1.227e+00  -3.025  0.00249 **  
h_beds                       1.976e-04  1.420e-04   1.392  0.16406     
h_urbanUrban                -9.856e-03  1.124e-01  -0.088  0.93013     
--- 
    Null deviance: 5696.8  on 7487  degrees of freedom 
Residual deviance: 5564.1  on 7469  degrees of freedom 
  (1269 observations deleted due to missingness) 
AIC: 5602.1 
 
Number of Fisher Scoring iterations: 5 
 
                                    OR       2.5 %     97.5 % 
(Intercept)                 0.20156404 0.048674067  0.7331511 
p_no_flag1                  1.26869369 1.075765856  1.4944982 
I(t_2008 * h_2008_poa_rate) 1.09927642 0.080028879 14.2618241 
I(t_2009 * h_2009_poa_rate) 0.99220612 0.430036889  2.2687152 
I(t_2010 * h_2010_poa_rate) 1.13168424 0.543613526  2.3398245 
I(t_2011 * h_2011_poa_rate) 1.03020002 0.374831414  2.7913097 
b_gndrF                     1.23939075 1.073670667  1.4310633 
b_dob70 Thru 74             1.13519672 0.906901365  1.4205809 
b_dob75 Thru 79             1.23807101 0.986998370  1.5525426 
b_dob80 Thru 84             1.39973330 1.115656280  1.7564844 
b_dob>84                    1.30925404 1.045162802  1.6420297 
c_util_day                  1.05592330 1.035749772  1.0762930 
c_cost                      1.00000113 0.999993539  1.0000085 
c_cost_outlier              0.72494864 0.474327398  1.0805484 
d_typeSURG                  0.87318538 0.734936649  1.0383025 
d_mdc05                     0.37714611 0.109387317  1.4930412 
d_mdcPRE                    0.02444599 0.001103334  0.2119443 
h_beds                      1.00019761 0.999914237  1.0004714 
h_urbanUrban                0.99019278 0.796894559  1.2384916 
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AMI 30-day hospital readmission 
 
Deviance Residuals:  
    Min       1Q   Median       3Q      Max   
-1.4397  -0.6235  -0.5526  -0.4822   2.8573   
 
Coefficients: 
                              Estimate Std. Error z value Pr(>|z|)     
(Intercept)                 -1.552e+00  6.671e-01  -2.326 0.020001 *   
p_no_flag1                   2.748e-01  7.364e-02   3.731 0.000191 *** 
I(t_2008 * h_2008_poa_rate) -7.544e-01  1.166e+00  -0.647 0.517763     
I(t_2009 * h_2009_poa_rate) -4.215e-01  3.753e-01  -1.123 0.261405     
I(t_2010 * h_2010_poa_rate) -3.367e-01  3.302e-01  -1.019 0.307974     
I(t_2011 * h_2011_poa_rate) -3.407e-01  4.507e-01  -0.756 0.449681     
b_gndrF                      1.486e-01  6.423e-02   2.314 0.020678 *   
b_dob70 Thru 74              1.578e-01  9.895e-02   1.594 0.110836     
b_dob75 Thru 79              1.760e-01  1.016e-01   1.731 0.083369 .   
b_dob80 Thru 84              3.384e-01  1.014e-01   3.336 0.000850 *** 
b_dob>84                     3.197e-01  1.006e-01   3.178 0.001483 **  
c_util_day                   5.401e-02  8.816e-03   6.127 8.97e-10 *** 
c_cost                      -7.282e-07  3.445e-06  -0.211 0.832615     
c_cost_outlier              -2.574e-01  1.833e-01  -1.404 0.160335     
d_typeSURG                  -4.898e-02  7.790e-02  -0.629 0.529560     
d_mdc05                     -6.467e-01  6.461e-01  -1.001 0.316805     
d_mdcPRE                    -3.591e+00  1.221e+00  -2.940 0.003280 **  
h_beds                       2.471e-04  1.238e-04   1.997 0.045849 *   
h_urbanUrban                 1.080e-02  9.911e-02   0.109 0.913204     
--- 
    Null deviance: 7024.6  on 7832  degrees of freedom 
Residual deviance: 6867.8  on 7814  degrees of freedom 
  (924 observations deleted due to missingness) 
AIC: 6905.8 
 
Number of Fisher Scoring iterations: 5 
 
                                   OR       2.5 %    97.5 % 
(Intercept)                 0.2118320 0.051804144 0.7583994 
p_no_flag1                  1.3162281 1.138868008 1.5200679 
I(t_2008 * h_2008_poa_rate) 0.4702947 0.046841548 4.5364865 
I(t_2009 * h_2009_poa_rate) 0.6560667 0.313321907 1.3646005 
I(t_2010 * h_2010_poa_rate) 0.7141350 0.372788144 1.3607424 
I(t_2011 * h_2011_poa_rate) 0.7112773 0.292524513 1.7122556 
b_gndrF                     1.1602227 1.022996558 1.3159354 
b_dob70 Thru 74             1.1708965 0.964341249 1.4215516 
b_dob75 Thru 79             1.1923811 0.976733755 1.4549850 
b_dob80 Thru 84             1.4026982 1.149721371 1.7114039 
b_dob>84                    1.3766519 1.130730533 1.6774501 
c_util_day                  1.0555004 1.037365355 1.0738679 
c_cost                      0.9999993 0.999992442 1.0000060 
c_cost_outlier              0.7730890 0.534841366 1.0983647 
d_typeSURG                  0.9522031 0.817632024 1.1097084 
d_mdc05                     0.5237544 0.152566418 2.0681798 
d_mdcPRE                    0.0275586 0.001251847 0.2360677 
h_beds                      1.0002471 1.000001361 1.0004870 
h_urbanUrban                1.0108611 0.834275414 1.2306134 
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HF 7-day hospital readmission  
 
Deviance Residuals:  
    Min       1Q   Median       3Q      Max   
-2.8696  -0.5933  -0.5591  -0.5222   2.5700   
 
Coefficients: 
                              Estimate Std. Error z value Pr(>|z|)     
(Intercept)                 -9.605e+00  7.246e+01  -0.133 0.894547     
p_no_flag1                   4.913e-02  2.867e-02   1.714 0.086527 .   
I(t_2008 * h_2008_poa_rate) -1.029e+00  3.998e-01  -2.574 0.010041 *   
I(t_2009 * h_2009_poa_rate) -3.847e-01  1.273e-01  -3.021 0.002516 **  
I(t_2010 * h_2010_poa_rate) -5.678e-01  1.152e-01  -4.930 8.21e-07 *** 
I(t_2011 * h_2011_poa_rate) -5.033e-01  1.528e-01  -3.293 0.000992 *** 
b_gndrF                      2.831e-02  2.221e-02   1.275 0.202426     
b_dob70 Thru 74              5.154e-02  4.128e-02   1.249 0.211796     
b_dob75 Thru 79             -4.176e-02  3.988e-02  -1.047 0.295138     
b_dob80 Thru 84             -1.052e-01  3.867e-02  -2.720 0.006529 **  
b_dob>84                    -2.032e-01  3.637e-02  -5.586 2.33e-08 *** 
c_util_day                   4.238e-02  2.843e-03  14.906  < 2e-16 *** 
c_cost                      -1.782e-06  2.115e-06  -0.843 0.399260     
c_cost_outlier              -2.983e-01  1.103e-01  -2.703 0.006870 **  
d_typeMED                    7.973e+00  7.246e+01   0.110 0.912387     
d_typeSURG                   7.713e+00  7.246e+01   0.106 0.915229     
d_mdc05                     -1.001e-01  1.699e-01  -0.589 0.555594     
d_mdcPRE                    -1.695e+00  4.975e-01  -3.408 0.000654 *** 
h_beds                       1.113e-04  4.286e-05   2.596 0.009427 **  
h_urbanUrban                 2.687e-03  3.134e-02   0.086 0.931658     
--- 
    Null deviance: 57392  on 66719  degrees of freedom 
Residual deviance: 56995  on 66700  degrees of freedom 
  (18265 observations deleted due to missingness) 
AIC: 57035 
 
Number of Fisher Scoring iterations: 8 
 
                                      OR        2.5 %      97.5 % 
(Intercept)                 6.738131e-05           NA 674.2185903 
p_no_flag1                  1.050361e+00 0.9928193339   1.1108972 
I(t_2008 * h_2008_poa_rate) 3.572520e-01 0.1626929264   0.7799475 
I(t_2009 * h_2009_poa_rate) 6.806702e-01 0.5301324519   0.8732434 
I(t_2010 * h_2010_poa_rate) 5.667659e-01 0.4520634022   0.7100185 
I(t_2011 * h_2011_poa_rate) 6.045468e-01 0.4477571023   0.8151641 
b_gndrF                     1.028712e+00 0.9849295272   1.0745168 
b_dob70 Thru 74             1.052890e+00 0.9711375754   1.1417095 
b_dob75 Thru 79             9.591040e-01 0.8870888651   1.0372251 
b_dob80 Thru 84             9.001662e-01 0.8345979151   0.9712075 
b_dob>84                    8.161428e-01 0.7601672322   0.8766672 
c_util_day                  1.043286e+00 1.0374861984   1.0491125 
c_cost                      9.999982e-01 0.9999940551   1.0000024 
c_cost_outlier              7.421145e-01 0.5956514667   0.9182336 
d_typeMED                   2.901369e+03 0.0002892812          NA 
d_typeSURG                  2.237969e+03 0.0002231548          NA 
d_mdc05                     9.047337e-01 0.6543352868   1.2752107 
d_mdcPRE                    1.835134e-01 0.0651264772   0.4626698 
h_beds                      1.000111e+00 1.0000267678   1.0001948 
h_urbanUrban                1.002691e+00 0.9431659906   1.0664445 
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HF 15-day hospital readmission  
 
Deviance Residuals:  
    Min       1Q   Median       3Q      Max   
-2.8428  -0.6729  -0.6378  -0.5934   2.4357   
 
Coefficients: 
                              Estimate Std. Error z value Pr(>|z|)     
(Intercept)                 -8.640e+00  4.395e+01  -0.197 0.844167     
p_no_flag1                   5.908e-02  2.545e-02   2.322 0.020247 *   
I(t_2008 * h_2008_poa_rate) -9.074e-01  3.538e-01  -2.565 0.010330 *   
I(t_2009 * h_2009_poa_rate) -4.001e-01  1.132e-01  -3.533 0.000411 *** 
I(t_2010 * h_2010_poa_rate) -4.924e-01  1.018e-01  -4.837 1.32e-06 *** 
I(t_2011 * h_2011_poa_rate) -5.263e-01  1.359e-01  -3.873 0.000107 *** 
b_gndrF                      1.588e-02  1.969e-02   0.807 0.419789     
b_dob70 Thru 74              4.776e-02  3.703e-02   1.290 0.197189     
b_dob75 Thru 79             -1.627e-02  3.560e-02  -0.457 0.647547     
b_dob80 Thru 84             -7.818e-02  3.451e-02  -2.266 0.023467 *   
b_dob>84                    -1.599e-01  3.243e-02  -4.931 8.18e-07 *** 
c_util_day                   3.959e-02  2.572e-03  15.396  < 2e-16 *** 
c_cost                      -1.765e-06  1.912e-06  -0.923 0.355902     
c_cost_outlier              -2.598e-01  9.828e-02  -2.644 0.008199 **  
d_typeMED                    7.264e+00  4.395e+01   0.165 0.868746     
d_typeSURG                   7.018e+00  4.395e+01   0.160 0.873141     
d_mdc05                     -7.795e-02  1.526e-01  -0.511 0.609476     
d_mdcPRE                    -1.614e+00  4.426e-01  -3.646 0.000266 *** 
h_beds                       8.425e-05  3.825e-05   2.202 0.027639 *   
h_urbanUrban                 1.578e-02  2.782e-02   0.567 0.570592     
--- 
    Null deviance: 69489  on 70191  degrees of freedom 
Residual deviance: 69074  on 70172  degrees of freedom 
  (14793 observations deleted due to missingness) 
AIC: 69114 
 
Number of Fisher Scoring iterations: 7 
 
                                      OR       2.5 %     97.5 % 
(Intercept)                 1.769088e-04          NA 34.0960777 
p_no_flag1                  1.060863e+00 1.009138783  1.1150039 
I(t_2008 * h_2008_poa_rate) 4.035663e-01 0.201299105  0.8058355 
I(t_2009 * h_2009_poa_rate) 6.702774e-01 0.536710502  0.8365970 
I(t_2010 * h_2010_poa_rate) 6.111304e-01 0.500440581  0.7459027 
I(t_2011 * h_2011_poa_rate) 5.907705e-01 0.452418247  0.7707034 
b_gndrF                     1.016012e+00 0.977571602  1.0560135 
b_dob70 Thru 74             1.048915e+00 0.975528482  1.1279498 
b_dob75 Thru 79             9.838582e-01 0.917635717  1.0550557 
b_dob80 Thru 84             9.247951e-01 0.864416386  0.9896303 
b_dob>84                    8.522345e-01 0.799891961  0.9083216 
c_util_day                  1.040385e+00 1.035153675  1.0456416 
c_cost                      9.999982e-01 0.999994475  1.0000020 
c_cost_outlier              7.711813e-01 0.634490228  0.9328838 
d_typeMED                   1.427258e+03 0.007381521         NA 
d_typeSURG                  1.116768e+03 0.005776270         NA 
d_mdc05                     9.250099e-01 0.690259256  1.2567010 
d_mdcPRE                    1.990949e-01 0.079659979  0.4554552 
h_beds                      1.000084e+00 1.000008922  1.0001589 
h_urbanUrban                1.015903e+00 0.962141261  1.0730009 
 
  
 
97 
HF 30-day hospital readmission  
 
Deviance Residuals:  
    Min       1Q   Median       3Q      Max   
-2.8062  -0.7619  -0.7247  -0.6118   2.2535   
 
Coefficients: 
                              Estimate Std. Error z value Pr(>|z|)     
(Intercept)                 -8.600e+00  4.395e+01  -0.196 0.844882     
p_no_flag1                   4.403e-02  2.278e-02   1.933 0.053275 .   
I(t_2008 * h_2008_poa_rate) -8.912e-01  3.156e-01  -2.824 0.004748 **  
I(t_2009 * h_2009_poa_rate) -3.760e-01  1.010e-01  -3.724 0.000196 *** 
I(t_2010 * h_2010_poa_rate) -3.875e-01  9.036e-02  -4.289 1.79e-05 *** 
I(t_2011 * h_2011_poa_rate) -5.045e-01  1.211e-01  -4.165 3.11e-05 *** 
b_gndrF                     -4.505e-03  1.754e-02  -0.257 0.797294     
b_dob70 Thru 74              4.383e-02  3.307e-02   1.325 0.185030     
b_dob75 Thru 79             -3.300e-02  3.183e-02  -1.037 0.299862     
b_dob80 Thru 84             -8.199e-02  3.078e-02  -2.663 0.007735 **  
b_dob>84                    -1.493e-01  2.887e-02  -5.169 2.35e-07 *** 
c_util_day                   3.725e-02  2.336e-03  15.946  < 2e-16 *** 
c_cost                      -2.909e-06  1.707e-06  -1.704 0.088318 .   
c_cost_outlier              -2.612e-01  8.905e-02  -2.934 0.003350 **  
d_typeMED                    7.545e+00  4.395e+01   0.172 0.863715     
d_typeSURG                   7.338e+00  4.395e+01   0.167 0.867421     
d_mdc05                     -8.886e-02  1.358e-01  -0.654 0.512860     
d_mdcPRE                    -1.169e+00  3.624e-01  -3.227 0.001250 **  
h_beds                       7.548e-05  3.424e-05   2.204 0.027499 *   
h_urbanUrban                 2.770e-02  2.486e-02   1.114 0.265237     
--- 
    Null deviance: 83631  on 74880  degrees of freedom 
Residual deviance: 83209  on 74861  degrees of freedom 
  (10104 observations deleted due to missingness) 
AIC: 83249 
 
Number of Fisher Scoring iterations: 7 
 
                                      OR       2.5 %     97.5 % 
(Intercept)                 1.841532e-04          NA 35.4874324 
p_no_flag1                  1.045010e+00 0.999303866  1.0926487 
I(t_2008 * h_2008_poa_rate) 4.101726e-01 0.220648469  0.7603947 
I(t_2009 * h_2009_poa_rate) 6.865848e-01 0.563176971  0.8366954 
I(t_2010 * h_2010_poa_rate) 6.787194e-01 0.568453847  0.8100843 
I(t_2011 * h_2011_poa_rate) 6.037869e-01 0.476017330  0.7653470 
b_gndrF                     9.955053e-01 0.961877855  1.0303386 
b_dob70 Thru 74             1.044800e+00 0.979267694  1.1147985 
b_dob75 Thru 79             9.675419e-01 0.909077651  1.0298856 
b_dob80 Thru 84             9.212843e-01 0.867407741  0.9786595 
b_dob>84                    8.613522e-01 0.814049269  0.9116137 
c_util_day                  1.037949e+00 1.033209566  1.0427142 
c_cost                      9.999971e-01 0.999993736  1.0000004 
c_cost_outlier              7.700944e-01 0.645640441  0.9154954 
d_typeMED                   1.890527e+03 0.009785442         NA 
d_typeSURG                  1.536866e+03 0.007955492         NA 
d_mdc05                     9.149756e-01 0.704013343  1.1995965 
d_mdcPRE                    3.105415e-01 0.148322924  0.6170213 
h_beds                      1.000075e+00 1.000008138  1.0001424 
h_urbanUrban                1.028082e+00 0.979291288  1.0795304 
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PN 7-day hospital readmission  
 
Deviance Residuals:  
    Min       1Q   Median       3Q      Max   
-3.5952  -0.4754  -0.4420  -0.4138   2.8430   
 
Coefficients: 
                              Estimate Std. Error z value Pr(>|z|)     
(Intercept)                 -2.287e+00  1.985e-01 -11.522  < 2e-16 *** 
p_no_flag1                   3.251e-02  3.860e-02   0.842 0.399677     
I(t_2008 * h_2008_poa_rate) -1.691e+00  5.366e-01  -3.152 0.001621 **  
I(t_2009 * h_2009_poa_rate) -4.553e-01  1.710e-01  -2.663 0.007747 **  
I(t_2010 * h_2010_poa_rate) -5.827e-01  1.547e-01  -3.766 0.000166 *** 
I(t_2011 * h_2011_poa_rate) -7.536e-01  2.067e-01  -3.647 0.000266 *** 
b_gndrF                     -1.282e-01  2.951e-02  -4.343 1.41e-05 *** 
b_dob70 Thru 74             -6.917e-03  5.436e-02  -0.127 0.898746     
b_dob75 Thru 79             -4.230e-03  5.232e-02  -0.081 0.935567     
b_dob80 Thru 84             -1.799e-02  5.097e-02  -0.353 0.724083     
b_dob>84                    -4.404e-02  4.766e-02  -0.924 0.355434     
c_util_day                   5.129e-02  3.817e-03  13.437  < 2e-16 *** 
c_cost                       1.982e-05  3.316e-06   5.976 2.28e-09 *** 
c_cost_outlier              -2.788e-01  1.334e-01  -2.091 0.036541 *   
d_typeSURG                  -3.472e-01  1.237e-01  -2.807 0.005003 **  
d_mdc04                     -1.418e-01  1.858e-01  -0.763 0.445304     
d_mdc25                     -1.198e+01  9.549e+01  -0.125 0.900135     
d_mdcPRE                    -2.407e+00  4.164e-01  -5.780 7.46e-09 *** 
h_beds                       1.508e-04  6.205e-05   2.430 0.015085 *   
h_urbanUrban                 3.296e-02  3.895e-02   0.846 0.397417     
--- 
    Null deviance: 34406  on 51856  degrees of freedom 
Residual deviance: 33885  on 51837  degrees of freedom 
  (13726 observations deleted due to missingness) 
AIC: 33925 
 
Number of Fisher Scoring iterations: 12 
 
                                      OR        2.5 %       97.5 % 
(Intercept)                 1.016017e-01 6.863456e-02 0.1495621445 
p_no_flag1                  1.033044e+00 9.574730e-01 1.1139018819 
I(t_2008 * h_2008_poa_rate) 1.842500e-01 6.397300e-02 0.5242673364 
I(t_2009 * h_2009_poa_rate) 6.342516e-01 4.532291e-01 0.8859454920 
I(t_2010 * h_2010_poa_rate) 5.583674e-01 4.119500e-01 0.7556053668 
I(t_2011 * h_2011_poa_rate) 4.706594e-01 3.134639e-01 0.7047051302 
b_gndrF                     8.797172e-01 8.303095e-01 0.9321354302 
b_dob70 Thru 74             9.931065e-01 8.928050e-01 1.1048905305 
b_dob75 Thru 79             9.957794e-01 8.989010e-01 1.1035554117 
b_dob80 Thru 84             9.821694e-01 8.890330e-01 1.0856680202 
b_dob>84                    9.569146e-01 8.719555e-01 1.0510904911 
c_util_day                  1.052623e+00 1.044766e+00 1.0605165545 
c_cost                      1.000020e+00 1.000013e+00 1.0000263242 
c_cost_outlier              7.566753e-01 5.799099e-01 0.9784711347 
d_typeSURG                  7.066762e-01 5.513216e-01 0.8957405595 
d_mdc04                     8.678123e-01 6.044250e-01 1.2533145937 
d_mdc25                     6.250311e-06 6.483132e-18 0.0007485875 
d_mdcPRE                    9.010667e-02 3.842014e-02 0.1977271363 
h_beds                      1.000151e+00 1.000028e+00 1.0002712804 
h_urbanUrban                1.033511e+00 9.578360e-01 1.1158513759 
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PN 15-day hospital readmission  
 
Deviance Residuals:  
    Min       1Q   Median       3Q      Max   
-3.5665  -0.5535  -0.5163  -0.4824   2.6565   
 
Coefficients: 
                              Estimate Std. Error z value Pr(>|z|)     
(Intercept)                 -1.938e+00  1.695e-01 -11.435  < 2e-16 *** 
p_no_flag1                   3.192e-02  3.333e-02   0.958  0.33818     
I(t_2008 * h_2008_poa_rate) -1.232e+00  4.612e-01  -2.670  0.00758 **  
I(t_2009 * h_2009_poa_rate) -3.443e-01  1.478e-01  -2.329  0.01984 *   
I(t_2010 * h_2010_poa_rate) -3.202e-01  1.324e-01  -2.418  0.01561 *   
I(t_2011 * h_2011_poa_rate) -5.288e-01  1.778e-01  -2.974  0.00294 **  
b_gndrF                     -1.382e-01  2.547e-02  -5.426 5.75e-08 *** 
b_dob70 Thru 74              4.682e-02  4.714e-02   0.993  0.32063     
b_dob75 Thru 79              2.418e-02  4.562e-02   0.530  0.59608     
b_dob80 Thru 84              3.229e-02  4.430e-02   0.729  0.46618     
b_dob>84                    -6.933e-03  4.158e-02  -0.167  0.86757     
c_util_day                   5.131e-02  3.382e-03  15.170  < 2e-16 *** 
c_cost                       1.718e-05  3.007e-06   5.715 1.10e-08 *** 
c_cost_outlier              -3.586e-01  1.213e-01  -2.957  0.00311 **  
d_typeSURG                  -2.627e-01  1.064e-01  -2.470  0.01351 *   
d_mdc04                     -2.135e-01  1.578e-01  -1.353  0.17602     
d_mdc25                     -1.427e+00  7.638e-01  -1.868  0.06175 .   
d_mdcPRE                    -2.390e+00  3.702e-01  -6.457 1.06e-10 *** 
h_beds                       1.264e-04  5.402e-05   2.340  0.01931 *   
h_urbanUrban                 3.491e-02  3.363e-02   1.038  0.29925     
--- 
    Null deviance: 43387  on 53978  degrees of freedom 
Residual deviance: 42781  on 53959  degrees of freedom 
  (11604 observations deleted due to missingness) 
AIC: 42821 
 
Number of Fisher Scoring iterations: 4 
 
                                    OR      2.5 %    97.5 % 
(Intercept)                 0.14404023 0.10316278 0.2005425 
p_no_flag1                  1.03243534 0.96694544 1.1019019 
I(t_2008 * h_2008_poa_rate) 0.29181112 0.11766714 0.7176032 
I(t_2009 * h_2009_poa_rate) 0.70873003 0.53013954 0.9462616 
I(t_2010 * h_2010_poa_rate) 0.72597931 0.55969459 0.9406741 
I(t_2011 * h_2011_poa_rate) 0.58932699 0.41551162 0.8342353 
b_gndrF                     0.87091822 0.82852768 0.9155203 
b_dob70 Thru 74             1.04793567 0.95552315 1.1495005 
b_dob75 Thru 79             1.02447785 0.93698060 1.1204973 
b_dob80 Thru 84             1.03281221 0.94710384 1.1267571 
b_dob>84                    0.99309131 0.91566590 1.0777600 
c_util_day                  1.05265283 1.04569208 1.0596504 
c_cost                      1.00001718 1.00001129 1.0000231 
c_cost_outlier              0.69867364 0.54889070 0.8832385 
d_typeSURG                  0.76895424 0.62189717 0.9438654 
d_mdc04                     0.80774745 0.59355629 1.1023757 
d_mdc25                     0.24007855 0.03702283 0.8684018 
d_mdcPRE                    0.09160096 0.04305309 0.1846164 
h_beds                      1.00012638 1.00001970 1.0002315 
h_urbanUrban                1.03552463 0.96967238 1.1063143 
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PN 30-day hospital readmission  
 
Deviance Residuals:  
    Min       1Q   Median       3Q      Max   
-3.4733  -0.6391  -0.5989  -0.5586   2.5760   
 
Coefficients: 
                              Estimate Std. Error z value Pr(>|z|)     
(Intercept)                 -1.646e+00  1.491e-01 -11.042  < 2e-16 *** 
p_no_flag1                   1.581e-02  2.923e-02   0.541 0.588603     
I(t_2008 * h_2008_poa_rate) -9.961e-01  4.025e-01  -2.475 0.013319 *   
I(t_2009 * h_2009_poa_rate) -1.880e-01  1.286e-01  -1.462 0.143870     
I(t_2010 * h_2010_poa_rate) -2.238e-01  1.156e-01  -1.936 0.052853 .   
I(t_2011 * h_2011_poa_rate) -3.147e-01  1.545e-01  -2.038 0.041586 *   
b_gndrF                     -1.216e-01  2.225e-02  -5.466 4.60e-08 *** 
b_dob70 Thru 74              7.051e-02  4.119e-02   1.712 0.086916 .   
b_dob75 Thru 79              2.490e-02  4.001e-02   0.622 0.533762     
b_dob80 Thru 84              6.060e-02  3.870e-02   1.566 0.117330     
b_dob>84                    -1.090e-03  3.642e-02  -0.030 0.976128     
c_util_day                   4.798e-02  3.037e-03  15.799  < 2e-16 *** 
c_cost                       1.700e-05  2.707e-06   6.279 3.41e-10 *** 
c_cost_outlier              -4.361e-01  1.122e-01  -3.888 0.000101 *** 
d_typeSURG                  -1.876e-01  9.254e-02  -2.027 0.042635 *   
d_mdc04                     -1.934e-01  1.387e-01  -1.395 0.163102     
d_mdc25                     -1.675e+00  7.562e-01  -2.216 0.026725 *   
d_mdcPRE                    -2.566e+00  3.487e-01  -7.360 1.84e-13 *** 
h_beds                       8.944e-05  4.781e-05   1.871 0.061382 .   
h_urbanUrban                 2.133e-02  2.923e-02   0.730 0.465518     
--- 
    Null deviance: 53789  on 56813  degrees of freedom 
Residual deviance: 53141  on 56794  degrees of freedom 
  (8769 observations deleted due to missingness) 
AIC: 53181 
 
Number of Fisher Scoring iterations: 4 
 
                                    OR      2.5 %    97.5 % 
(Intercept)                 0.19281095 0.14381271 0.2580375 
p_no_flag1                  1.01593730 0.95922144 1.0756947 
I(t_2008 * h_2008_poa_rate) 0.36931038 0.16731951 0.8104148 
I(t_2009 * h_2009_poa_rate) 0.82863235 0.64371362 1.0657538 
I(t_2010 * h_2010_poa_rate) 0.79946182 0.63714680 1.0024049 
I(t_2011 * h_2011_poa_rate) 0.72999342 0.53896848 0.9874436 
b_gndrF                     0.88547125 0.84769454 0.9249622 
b_dob70 Thru 74             1.07306042 0.98989804 1.1633749 
b_dob75 Thru 79             1.02521140 0.94797902 1.1089743 
b_dob80 Thru 84             1.06247403 0.98501848 1.1463686 
b_dob>84                    0.99891080 0.93029526 1.0730636 
c_util_day                  1.04915008 1.04292068 1.0554113 
c_cost                      1.00001700 1.00001171 1.0000223 
c_cost_outlier              0.64657704 0.51754106 0.8035335 
d_typeSURG                  0.82894718 0.68975658 0.9915368 
d_mdc04                     0.82413363 0.62843235 1.0826608 
d_mdc25                     0.18724450 0.02919180 0.6650142 
d_mdcPRE                    0.07681597 0.03771027 0.1485825 
h_beds                      1.00008944 0.99999519 1.0001826 
h_urbanUrban                1.02156400 0.96480683 1.0819582 
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Appendix	  D	  –	  POA	  Frequency	  Data	  
The following pages contain cross tabulation output from R for each ICD code used 
in this study showing POA counts and proportions.  This data represents “potential 
index” claims from the data sets extracted for statistical modeling.  POA in this table is 
defined in Section 3.4.2.  It does not contain tabulations for all available claims. 
 
The format of each cell is defines as: 
|-------------------------| 
|                       N | 
|           N / Row Total | 
|         N / Table Total | 
|-------------------------| 
 
              | POA 
 AMI ICD Codes|   0 (yes) |    1 (no) | Row Total |  
--------------|-----------|-----------|-----------| 
        41000 |         1 |         1 |         2 |  
              |     0.500 |     0.500 |     0.000 |  
              |     0.000 |     0.000 |           |  
--------------|-----------|-----------|-----------| 
        41001 |       348 |       226 |       574 |  
              |     0.606 |     0.394 |     0.066 |  
              |     0.040 |     0.026 |           |  
--------------|-----------|-----------|-----------| 
        41010 |         7 |         2 |         9 |  
              |     0.778 |     0.222 |     0.001 |  
              |     0.001 |     0.000 |           |  
--------------|-----------|-----------|-----------| 
        41011 |      1474 |       750 |      2224 |  
              |     0.663 |     0.337 |     0.254 |  
              |     0.169 |     0.086 |           |  
--------------|-----------|-----------|-----------| 
        41020 |         1 |         0 |         1 |  
              |     1.000 |     0.000 |     0.000 |  
              |     0.000 |     0.000 |           |  
--------------|-----------|-----------|-----------| 
        41021 |       336 |       170 |       506 |  
              |     0.664 |     0.336 |     0.058 |  
              |     0.038 |     0.019 |           |  
--------------|-----------|-----------|-----------| 
        41031 |       205 |       112 |       317 |  
              |     0.647 |     0.353 |     0.036 |  
              |     0.023 |     0.013 |           |  
--------------|-----------|-----------|-----------| 
        41040 |         6 |         3 |         9 |  
              |     0.667 |     0.333 |     0.001 |  
              |     0.001 |     0.000 |           |  
--------------|-----------|-----------|-----------| 
        41041 |      1900 |       936 |      2836 |  
              |     0.670 |     0.330 |     0.324 |  
              |     0.217 |     0.107 |           |  
--------------|-----------|-----------|-----------| 
        41050 |         1 |         1 |         2 |  
              |     0.500 |     0.500 |     0.000 |  
              |     0.000 |     0.000 |           |  
--------------|-----------|-----------|-----------| 
        41051 |       197 |       113 |       310 |  
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              |     0.635 |     0.365 |     0.035 |  
              |     0.023 |     0.013 |           |  
--------------|-----------|-----------|-----------| 
        41081 |       177 |        45 |       222 |  
              |     0.797 |     0.203 |     0.025 |  
              |     0.020 |     0.005 |           |  
--------------|-----------|-----------|-----------| 
        41090 |        33 |         4 |        37 |  
              |     0.892 |     0.108 |     0.004 |  
              |     0.004 |     0.000 |           |  
--------------|-----------|-----------|-----------| 
        41091 |      1322 |       376 |      1698 |  
              |     0.779 |     0.221 |     0.194 |  
              |     0.151 |     0.043 |           |  
--------------|-----------|-----------|-----------| 
 Column Total |      6008 |      2739 |      8747 |  
 
 
 
             | POA 
HF ICD Codes |   0 (yes) |    1 (no) | Row Total |  
-------------|-----------|-----------|-----------| 
        4280 |     25124 |      4705 |     29829 |  
             |     0.842 |     0.158 |     0.351 |  
             |     0.296 |     0.055 |           |  
-------------|-----------|-----------|-----------| 
        4281 |       155 |        28 |       183 |  
             |     0.847 |     0.153 |     0.002 |  
             |     0.002 |     0.000 |           |  
-------------|-----------|-----------|-----------| 
        4289 |        20 |         3 |        23 |  
             |     0.870 |     0.130 |     0.000 |  
             |     0.000 |     0.000 |           |  
-------------|-----------|-----------|-----------| 
       40201 |       176 |        28 |       204 |  
             |     0.863 |     0.137 |     0.002 |  
             |     0.002 |     0.000 |           |  
-------------|-----------|-----------|-----------| 
       40211 |        35 |        13 |        48 |  
             |     0.729 |     0.271 |     0.001 |  
             |     0.000 |     0.000 |           |  
-------------|-----------|-----------|-----------| 
       40291 |      1892 |       368 |      2260 |  
             |     0.837 |     0.163 |     0.027 |  
             |     0.022 |     0.004 |           |  
-------------|-----------|-----------|-----------| 
       40401 |       163 |        71 |       234 |  
             |     0.697 |     0.303 |     0.003 |  
             |     0.002 |     0.001 |           |  
-------------|-----------|-----------|-----------| 
       40403 |        66 |        10 |        76 |  
             |     0.868 |     0.132 |     0.001 |  
             |     0.001 |     0.000 |           |  
-------------|-----------|-----------|-----------| 
       40411 |        51 |        16 |        67 |  
             |     0.761 |     0.239 |     0.001 |  
             |     0.001 |     0.000 |           |  
-------------|-----------|-----------|-----------| 
       40413 |         6 |         3 |         9 |  
             |     0.667 |     0.333 |     0.000 |  
             |     0.000 |     0.000 |           |  
-------------|-----------|-----------|-----------| 
       40491 |      1822 |       722 |      2544 |  
             |     0.716 |     0.284 |     0.030 |  
             |     0.021 |     0.009 |           |  
-------------|-----------|-----------|-----------| 
       40493 |       416 |       146 |       562 |  
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             |     0.740 |     0.260 |     0.007 |  
             |     0.005 |     0.002 |           |  
-------------|-----------|-----------|-----------| 
       42820 |      1124 |       208 |      1332 |  
             |     0.844 |     0.156 |     0.016 |  
             |     0.013 |     0.002 |           |  
-------------|-----------|-----------|-----------| 
       42821 |      3699 |       948 |      4647 |  
             |     0.796 |     0.204 |     0.055 |  
             |     0.044 |     0.011 |           |  
-------------|-----------|-----------|-----------| 
       42822 |      1094 |       232 |      1326 |  
             |     0.825 |     0.175 |     0.016 |  
             |     0.013 |     0.003 |           |  
-------------|-----------|-----------|-----------| 
       42823 |     11279 |      3738 |     15017 |  
             |     0.751 |     0.249 |     0.177 |  
             |     0.133 |     0.044 |           |  
-------------|-----------|-----------|-----------| 
       42830 |      2429 |       461 |      2890 |  
             |     0.840 |     0.160 |     0.034 |  
             |     0.029 |     0.005 |           |  
-------------|-----------|-----------|-----------| 
       42831 |      3669 |       934 |      4603 |  
             |     0.797 |     0.203 |     0.054 |  
             |     0.043 |     0.011 |           |  
-------------|-----------|-----------|-----------| 
       42832 |       701 |       154 |       855 |  
             |     0.820 |     0.180 |     0.010 |  
             |     0.008 |     0.002 |           |  
-------------|-----------|-----------|-----------| 
       42833 |      8920 |      2885 |     11805 |  
             |     0.756 |     0.244 |     0.139 |  
             |     0.105 |     0.034 |           |  
-------------|-----------|-----------|-----------| 
       42840 |       312 |        61 |       373 |  
             |     0.836 |     0.164 |     0.004 |  
             |     0.004 |     0.001 |           |  
-------------|-----------|-----------|-----------| 
       42841 |       726 |       214 |       940 |  
             |     0.772 |     0.228 |     0.011 |  
             |     0.009 |     0.003 |           |  
-------------|-----------|-----------|-----------| 
       42842 |       206 |        51 |       257 |  
             |     0.802 |     0.198 |     0.003 |  
             |     0.002 |     0.001 |           |  
-------------|-----------|-----------|-----------| 
       42843 |      3548 |      1247 |      4795 |  
             |     0.740 |     0.260 |     0.056 |  
             |     0.042 |     0.015 |           |  
-------------|-----------|-----------|-----------| 
Column Total |     67633 |     17246 |     84879 |   
 
   
 
             | POA 
PN ICD Codes |   0 (yes) |    1 (no) | Row Total |  
-------------|-----------|-----------|-----------| 
         481 |       841 |       223 |      1064 |  
             |     0.790 |     0.210 |     0.016 |  
             |     0.013 |     0.003 |           |  
-------------|-----------|-----------|-----------| 
         485 |       600 |       121 |       721 |  
             |     0.832 |     0.168 |     0.011 |  
             |     0.009 |     0.002 |           |  
-------------|-----------|-----------|-----------| 
         486 |     44662 |     10510 |     55172 |  
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             |     0.810 |     0.190 |     0.843 |  
             |     0.682 |     0.161 |           |  
-------------|-----------|-----------|-----------| 
        4800 |         3 |         3 |         6 |  
             |     0.500 |     0.500 |     0.000 |  
             |     0.000 |     0.000 |           |  
-------------|-----------|-----------|-----------| 
        4801 |        23 |         6 |        29 |  
             |     0.793 |     0.207 |     0.000 |  
             |     0.000 |     0.000 |           |  
-------------|-----------|-----------|-----------| 
        4802 |         4 |         2 |         6 |  
             |     0.667 |     0.333 |     0.000 |  
             |     0.000 |     0.000 |           |  
-------------|-----------|-----------|-----------| 
        4808 |        10 |         4 |        14 |  
             |     0.714 |     0.286 |     0.000 |  
             |     0.000 |     0.000 |           |  
-------------|-----------|-----------|-----------| 
        4809 |       205 |        55 |       260 |  
             |     0.788 |     0.212 |     0.004 |  
             |     0.003 |     0.001 |           |  
-------------|-----------|-----------|-----------| 
        4820 |       278 |       104 |       382 |  
             |     0.728 |     0.272 |     0.006 |  
             |     0.004 |     0.002 |           |  
-------------|-----------|-----------|-----------| 
        4821 |       999 |       422 |      1421 |  
             |     0.703 |     0.297 |     0.022 |  
             |     0.015 |     0.006 |           |  
-------------|-----------|-----------|-----------| 
        4822 |       183 |        65 |       248 |  
             |     0.738 |     0.262 |     0.004 |  
             |     0.003 |     0.001 |           |  
-------------|-----------|-----------|-----------| 
        4829 |       939 |       300 |      1239 |  
             |     0.758 |     0.242 |     0.019 |  
             |     0.014 |     0.005 |           |  
-------------|-----------|-----------|-----------| 
        4830 |        76 |        22 |        98 |  
             |     0.776 |     0.224 |     0.001 |  
             |     0.001 |     0.000 |           |  
-------------|-----------|-----------|-----------| 
        4831 |         4 |         3 |         7 |  
             |     0.571 |     0.429 |     0.000 |  
             |     0.000 |     0.000 |           |  
-------------|-----------|-----------|-----------| 
        4838 |        36 |        10 |        46 |  
             |     0.783 |     0.217 |     0.001 |  
             |     0.001 |     0.000 |           |  
-------------|-----------|-----------|-----------| 
        4870 |       438 |        99 |       537 |  
             |     0.816 |     0.184 |     0.008 |  
             |     0.007 |     0.002 |           |  
-------------|-----------|-----------|-----------| 
       48230 |       109 |        33 |       142 |  
             |     0.768 |     0.232 |     0.002 |  
             |     0.002 |     0.001 |           |  
-------------|-----------|-----------|-----------| 
       48231 |         4 |         6 |        10 |  
             |     0.400 |     0.600 |     0.000 |  
             |     0.000 |     0.000 |           |  
-------------|-----------|-----------|-----------| 
       48232 |        10 |         2 |        12 |  
             |     0.833 |     0.167 |     0.000 |  
             |     0.000 |     0.000 |           |  
-------------|-----------|-----------|-----------| 
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       48239 |        62 |        19 |        81 |  
             |     0.765 |     0.235 |     0.001 |  
             |     0.001 |     0.000 |           |  
-------------|-----------|-----------|-----------| 
       48240 |        42 |        13 |        55 |  
             |     0.764 |     0.236 |     0.001 |  
             |     0.001 |     0.000 |           |  
-------------|-----------|-----------|-----------| 
       48241 |       690 |       126 |       816 |  
             |     0.846 |     0.154 |     0.012 |  
             |     0.011 |     0.002 |           |  
-------------|-----------|-----------|-----------| 
       48242 |       831 |       507 |      1338 |  
             |     0.621 |     0.379 |     0.020 |  
             |     0.013 |     0.008 |           |  
-------------|-----------|-----------|-----------| 
       48249 |        39 |        14 |        53 |  
             |     0.736 |     0.264 |     0.001 |  
             |     0.001 |     0.000 |           |  
-------------|-----------|-----------|-----------| 
       48281 |        12 |         5 |        17 |  
             |     0.706 |     0.294 |     0.000 |  
             |     0.000 |     0.000 |           |  
-------------|-----------|-----------|-----------| 
       48282 |       154 |        83 |       237 |  
             |     0.650 |     0.350 |     0.004 |  
             |     0.002 |     0.001 |           |  
-------------|-----------|-----------|-----------| 
       48283 |       977 |       352 |      1329 |  
             |     0.735 |     0.265 |     0.020 |  
             |     0.015 |     0.005 |           |  
-------------|-----------|-----------|-----------| 
       48284 |        62 |        30 |        92 |  
             |     0.674 |     0.326 |     0.001 |  
             |     0.001 |     0.000 |           |  
-------------|-----------|-----------|-----------| 
       48289 |        31 |        11 |        42 |  
             |     0.738 |     0.262 |     0.001 |  
             |     0.000 |     0.000 |           |  
-------------|-----------|-----------|-----------| 
Column Total |     52324 |     13150 |     65474 |  
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> CrossTable(AMI$c_surgery, AMI$y30b, chisq=TRUE); 
 
  
   Cell Contents 
|-------------------------| 
|                       N | 
| Chi-square contribution | 
|           N / Row Total | 
|           N / Col Total | 
|         N / Table Total | 
|-------------------------| 
 
  
Total Observations in Table:  8028  
 
  
              | AMI$y30b  
AMI$c_surgery |         0 |         1 | Row Total |  
--------------|-----------|-----------|-----------| 
            0 |      1223 |       236 |      1459 |  
              |     0.018 |     0.089 |           |  
              |     0.838 |     0.162 |     0.182 |  
              |     0.182 |     0.178 |           |  
              |     0.152 |     0.029 |           |  
--------------|-----------|-----------|-----------| 
            1 |      5481 |      1088 |      6569 |  
              |     0.004 |     0.020 |           |  
              |     0.834 |     0.166 |     0.818 |  
              |     0.818 |     0.822 |           |  
              |     0.683 |     0.136 |           |  
--------------|-----------|-----------|-----------| 
 Column Total |      6704 |      1324 |      8028 |  
              |     0.835 |     0.165 |           |  
--------------|-----------|-----------|-----------| 
 
  
Statistics for All Table Factors 
 
 
Pearson's Chi-squared test  
------------------------------------------------------------ 
Chi^2 =  0.1299469     d.f. =  1     p =  0.7184871  
 
Pearson's Chi-squared test with Yates' continuity correction  
------------------------------------------------------------ 
Chi^2 =  0.1033545     d.f. =  1     p =  0.7478407  
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> CrossTable(AMI$c_surgery, AMI$p_no_flag, chisq=TRUE); 
 
  
   Cell Contents 
|-------------------------| 
|                       N | 
| Chi-square contribution | 
|           N / Row Total | 
|           N / Col Total | 
|         N / Table Total | 
|-------------------------| 
 
  
Total Observations in Table:  8747  
 
  
              | AMI$p_no_flag  
AMI$c_surgery |         0 |         1 | Row Total |  
--------------|-----------|-----------|-----------| 
            0 |      1378 |       210 |      1588 |  
              |    75.653 |   165.946 |           |  
              |     0.868 |     0.132 |     0.182 |  
              |     0.229 |     0.077 |           |  
              |     0.158 |     0.024 |           |  
--------------|-----------|-----------|-----------| 
            1 |      4630 |      2529 |      7159 |  
              |    16.781 |    36.810 |           |  
              |     0.647 |     0.353 |     0.818 |  
              |     0.771 |     0.923 |           |  
              |     0.529 |     0.289 |           |  
--------------|-----------|-----------|-----------| 
 Column Total |      6008 |      2739 |      8747 |  
              |     0.687 |     0.313 |           |  
--------------|-----------|-----------|-----------| 
 
  
Statistics for All Table Factors 
 
 
Pearson's Chi-squared test  
------------------------------------------------------------ 
Chi^2 =  295.1906     d.f. =  1     p =  3.678035e-66  
 
Pearson's Chi-squared test with Yates' continuity correction  
------------------------------------------------------------ 
Chi^2 =  294.1638     d.f. =  1     p =  6.156239e-66  
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> CrossTable(AMI$y30b, AMI$p_no_flag, chisq=TRUE); 
 
  
   Cell Contents 
|-------------------------| 
|                       N | 
| Chi-square contribution | 
|           N / Row Total | 
|           N / Col Total | 
|         N / Table Total | 
|-------------------------| 
 
  
Total Observations in Table:  8020  
 
  
             | AMI$p_no_flag  
    AMI$y30b |         0 |         1 | Row Total |  
-------------|-----------|-----------|-----------| 
           0 |      4739 |      1958 |      6697 |  
             |     2.064 |     4.658 |           |  
             |     0.708 |     0.292 |     0.835 |  
             |     0.853 |     0.795 |           |  
             |     0.591 |     0.244 |           |  
-------------|-----------|-----------|-----------| 
           1 |       819 |       504 |      1323 |  
             |    10.445 |    23.581 |           |  
             |     0.619 |     0.381 |     0.165 |  
             |     0.147 |     0.205 |           |  
             |     0.102 |     0.063 |           |  
-------------|-----------|-----------|-----------| 
Column Total |      5558 |      2462 |      8020 |  
             |     0.693 |     0.307 |           |  
-------------|-----------|-----------|-----------| 
 
  
Statistics for All Table Factors 
 
 
Pearson's Chi-squared test  
------------------------------------------------------------ 
Chi^2 =  40.74791     d.f. =  1     p =  1.731882e-10  
 
Pearson's Chi-squared test with Yates' continuity correction  
------------------------------------------------------------ 
Chi^2 =  40.3326     d.f. =  1     p =  2.14205e-10  
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> CrossTable(AMI$y30b, AMI$test_poa_surgery, chisq=TRUE); 
 
  
   Cell Contents 
|-------------------------| 
|                       N | 
| Chi-square contribution | 
|           N / Row Total | 
|           N / Col Total | 
|         N / Table Total | 
|-------------------------| 
 
  
Total Observations in Table:  8028  
 
  
             | AMI$test_poa_surgery  
    AMI$y30b |         0 |         1 | Row Total |  
-------------|-----------|-----------|-----------| 
           0 |      4900 |      1804 |      6704 |  
             |     1.944 |     4.913 |           |  
             |     0.731 |     0.269 |     0.835 |  
             |     0.852 |     0.793 |           |  
             |     0.610 |     0.225 |           |  
-------------|-----------|-----------|-----------| 
           1 |       852 |       472 |      1324 |  
             |     9.844 |    24.878 |           |  
             |     0.644 |     0.356 |     0.165 |  
             |     0.148 |     0.207 |           |  
             |     0.106 |     0.059 |           |  
-------------|-----------|-----------|-----------| 
Column Total |      5752 |      2276 |      8028 |  
             |     0.716 |     0.284 |           |  
-------------|-----------|-----------|-----------| 
 
  
Statistics for All Table Factors 
 
 
Pearson's Chi-squared test  
------------------------------------------------------------ 
Chi^2 =  41.58003     d.f. =  1     p =  1.131429e-10  
 
Pearson's Chi-squared test with Yates' continuity correction  
------------------------------------------------------------ 
Chi^2 =  41.15087     d.f. =  1     p =  1.409205e-10  
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Appendix	  E	  	  
It is tempting to arrive at the first answer and stop without being mindful of 
alternatives or without completing the rigor necessary to demonstrate even to yourself 
that your answer really is the answer.  This, however, is not consistent with the scientific 
method, which strives for considered experimentation, reproducibility, and 
communication of results.  In this section, I would like to address the middle item: 
reproducibility.   
After assessing the state of the raw input data files, the need for care became obvious 
when several “common” fields did not contain data encoded in a similar way.  Ignoring 
this difference in coding could have led to a significant waste of time or possibly even 
erroneous results.   Each LDS file is accompanied by a data dictionary defining the 
individual data fields, layout, data type, and contents.  Extending these definitions to 
secondary data such as ResDAC field decode definitions, U.S. census data, CMS ICD-9 
definitions, etc., means managing dozens of data sources and their associated 
documentation.  Research is an iterative process of considering options to choose a 
direction, extending an effort in that direction, and building upon what has come before.  
Working through a few iterations is manageable, but when numerous iterations flow in 
quick succession, it can be difficult to judge when an error slipped into the mix.  
Managing the iterations means both process (what are you doing and how are you doing 
it) and product (a database, queries, graphs, extracts, models, regression output).   
To manage and ensure accountability for all items in the research effort, I found the 
following steps beneficial, as they gave me confidence in my work its results by making 
the process repeatable.   
Secure	  the	  Input	  Data	  
Create a data management directory containing the following subdirectories: “raw”, 
“docs”, “load”.  Save all data used into the “raw” directory or subdirectory.  Toggle file 
permissions to “read-only” mode to prevent accidents.  Run an MD5 checksum on the 
file.  Add a comment to a Sources document located in “docs” containing: the name of 
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your source file, its checksum, where the file originated, a link to it, and its data 
dictionary, help page, or manual.  Save the data dictionary into “docs” as well.  Make this 
file writeable and add comments, highlighting, and references.  In my case, I created a 
database to normalize my data.  Script everything that builds the ultimate dataset.  
Manual processes are subject to error even if those steps are “documented.”  All scripts, 
tools, and applications in the afferent flow are saved in “load” directory.  Within all of 
my code, I left enough landmarks via print statements to isolate an error when it would 
arise.  Which application was running?  What was it doing?  All of this information is 
saved in log files located in “docs” for future reference.   
Automate	  Your	  Work	  
In cases such as with input data for this study, the original source data was not 
directly usable.  It had to be altered to a normalized form.  A small set of changes to input 
data can be done confidently.  A mountain of changes cannot.  Likewise, manually 
checking a few hundred rows of data for “equivalence” is not a bit task.  Doing so 
repeatedly is tedious.  Doing so for 2.8M rows is impossible.  In this study, I built a loop-
back data comparison tool to read data from the database and compare it to the original 
data file.  Automating the build and check functions makes it possible to rebuild the 
database overnight.  Build in some fault tolerance.  Don’t stop on the first error.  Some 
data fields do contain garbage.  Note it and continue.  Then review the output in the log 
file.  One-off errors are probably not a worry, but 190,000 of the same error may need 
looking into. 
Input source data is their data.  The resulting dataset it your data.  You get to define 
relationships and meaning.  Once the input process is secured, build the intermediate 
data, which will become the base for the statistical extract.  Automate this step as well.  
Save these scripts into their own directory apart from others.  These scripts tend to 
change as understanding of data and identification of ultimate target change over time.  
Break these apart into distinct pieces.  For this study, patient history represents one 
distinct set of data and will need a separate set of activities to produce them.  These were 
distinct from integrating hospital information into the mix, and therefore had its own 
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directory for source.  Likewise for efferent flow.  Create separate directories for each type 
of extract.  Document what you are doing for yourself. 
Use	  Version	  Control	  
Version control helps manage the daily source change by tracking it for you.  Once 
daily effort has led to a successful build, save a copy of the project.  Save all source files 
and documentation.  Source data doesn’t change, and doesn’t need to be part of the 
versioning process.  Versioning captures the state of all the pieces used.  Some pieces 
vary more than others.  Once those are at a stable point, version the project again, and 
then continue to modify.  For a small group project, one doesn’t need the spectrum of 
features available for large projects.  I chose Git[47].  Read the documentation and 
incorporate it into daily workflow.  When things do go awry, the version tool can show 
changes between what is in the source files now and what was there when it last worked.   
Version control shows what changes.  It can’t show why it changes.  Keep a running 
changes document in the “docs” directory.  This is for you to keep track of yourself and 
your actions.  Such a document is useful when planning your next set of changes.   
Snap a version when you show someone your results, even if at an intermediate state, 
particularly statistical results, graphs, charts, tables.  Use temporary directories when 
making moment runs.  Once stable, save visualizations and the code used to make the 
visualization in a directory in the project directory.  Snap a version with a comment. 
Iterate	  
The daily grind is not iteration; it’s work.  Iteration is the longer view.  What 
happened last month?  What do I need to accomplish this week?  How does that fit into 
my ultimate goal?  This mindset preserves the work and products in such a way as to 
make future work more efficient.  Making changes to a database or dataset as 
understanding of data and relationships changes is easy once the process is automated.  It 
is repeatable.  The repeatability fosters both confidence in the result and an ability to 
experiment.  Capture what is going on in a version file in the “docs” directory.  Avoid the 
temptation to just dive into the problem.  Think about the immediate changes within the 
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context of the larger iteration.  Finish one change before starting another.  Snap a version.  
Update your own documentation so you don’t forget something, or loose track of what 
you were doing, or why.   
Backup	  Your	  Work	  
Version control is a way of “backing up” a logical state of your source code.  It is not 
a physical backup.  Disk space is cheap.  Buy an external drive and use it regularly.  
Backup everything: original source files, source code, datasets, database, output 
directories, and documentation, anything you’d be “sad” to loose.  Keep the backup safe.  
Accidents happen.  Lightning happens.  Theft happens.  Stupidity happens.  Be an adult.  
Learn about backup strategies and use them. 
Define	  a	  Baseline	  and	  Stick	  to	  It	  
Building up a research database requires utilizing dozens of applications, libraries, 
tools, modules, etc., and writing custom scripts and applications on top of those.  In my 
case, these reside on a laptop.  All of these have their own version.  Stick to the major 
version throughout the life of your project.  Collect the names, versions, any notes on 
installation, configuration, setup, etc. into a “baseline” document in your “docs” 
directory.  This baseline is crucial to progress.  Applying something such as an operating 
system update may damage the baseline, rendering it unusable.  Correcting a baseline 
change may not be trivial.  Downloading a new version of an application may render 
additional libraries as “out of date” and could require purchase of new upgrades.  This 
ricochet is time consuming and frustrating at the end of the project.  Resist the 
temptation.  Plan for it.  Snap a version of all code.  Make a backup of the project.  Find 
out what will need changing before applying any change.  Security patches are generally 
not as catastrophic as operating system upgrades. 
